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ABSTRACTS




Ultrapure water for dialysate contributes to a lower activation state (geom. mean (95%CI), 26.4 (23.7–29.5) vs. 17.0 (15.4–18.8)mU/mL in
the normoalbuminuric group, p,0.0001). Prorenin was also elevatedof peripheral blood mononuclear cells. Rae Akrum, M. Frohlich, A.F.
(742 (652–850) vs. 294 (170–320)mU/mL, p,0.0001). Proliferative reti-Gerritsen, M.R. Daha, P.C. Chang. Dept. of Nephrology, University
nopathy had an independent, additive effect on plasma prorenin. DNHospital Leiden, The Netherlands. Endotoxin (LPS) in dialysate is
was associated with a Bgl I RFLP in the first intron of the renin geneknown to enhance production of cytokines by peripheral blood mono-
(p50.037), but not with other polymorphisms in the renin gene.nuclear cells (PBMC’s). Recently, at our dialysis unit a new ultrapure
waterproduction system, using double reversed osmosis in sequence,
was implemented. The use of this water for the production of dialysate Bgl I genotype BB Bb bb
led to a consistent decrease in endotoxin levels from 10–$50 EU/ml
Nephropathic pts. (n) 22 70 107to below 0.02 EU/ml. To investigate if this practically endotoxin free
Normoalbum. pts. (n) 19 91 82water for dialysate leads to lower inflammatory mediators in vivo,
plasma measurements of endotoxin, IL-6, TNFa, C3a, b2microglobulin
A trend for association of higher prorenin levels with the DN-associ-(b2M), C-reactive protein (CRP), AP50 and CH50 were performed in ated allele of this renin polymorphism was observed in patients withplasma collected from 28 chronic HD patients, before, 5 weeks, and
nephropathy (BB1Bb vs. bb, p50.07). The results indicate that DN4 months after installation of the new water treatment system. 15
is not a low renin-, but a high renin-high prorenin state, to which thePatients completed the protocol. From isolated PBMC’s TNFa and
renin gene may contribute. An increased expression of the renin geneIL-6 production and TNFa mRNA expression was measured. All other could be involved in the pathogenesis of DN.
treatment parameters were kept constant. We demonstrate that re-
moval of LPS results in a statistically significant decrease of pre- and
postdialytic plasma endotoxin levels from 0.68760.267 (M6SE) to Nifedipine and enalapril treatment increases systemic nitric oxide activ-
0.20860.035 and 0.08360.025 EU/ml after 5 weeks, and 4 months, ity in essential hypertensives. L.T. Dijkhorst-Oei, J.J. Beutler, H.A.
respectively. The IL-6 concentration declined from 13.762.4 pg/ml and Koomans and T.J. Rabelink; Dept. of Nephrology, University Hospital
1663.9 pg/ml, before and after HD respectively, to undetectable levels Utrecht, The Netherlands. Objective: Nitric oxide (NO) is a vasodilating
(p,0.01). C3a concentration before and after HD decreased from and blood pressure lowering substance. To investigate whether certain
6856122 ng/ml and 553686 ng/ml, to 464670 ng/ml and 398675 ng/ antihypertensives, such as calcium antagonists and angio-tensin-con-
ml after 5 weeks, and to 452681 (p,0.05) and 248676 after 4 months verting enzyme inhibitors, increase NO activity, we assessed systemic
(p,0.01). Plasma TNFa and b2M levels consistently decreased during and renal vascular sensitivity to NO synthase inhibition in hyperten-
dialysis, but were unaffected by the use of the ultrapure water treatment sives on and off medication. Methods: Ten essential hypertensive pa-
system (p,0.05). AP50 increased during dialysis, indicating comple- tients (22–51 yr) were studied 3 times: after $4 weeks off medication
ment activation, and this disappeared on the new dialysate. CH50 (OFF), after 3 weeks nifedipine (NIF) GITS 60 mg/day and after 3
levels remained unchanged. Isolated PBMC’s produced much less IL-6 weeks enalapril (ENA) 20 mg BID. On each occasion, 24-hr blood
pressure registration was performed and on the next day a PAH-clear-and TNFa (both p,0.01) after the introduction of the ultrapure dialy-
ance study: after 1 hr baseline a 3-hr dose-response curve was made forsate. Expression of mRNA for TNFa in PBMC’s was clearly decreased
i.v infused nG-monomethyl-l-arginine (l-NMMA): 0.75→1.5→3.0 mg/4 weeks after the new water system came in use. These findings indicate
kg/hr. Systemic and renal vascular resistances (SVR and RVR) werethat dialysate in which LPS is absent, contributes to a lower activation
calculated by dividing oscillometric mean arterial pressure (MAP) bystate of PBMC’s and lower production of inflammatory mediators in
bio-impedance cardiac index (CI) and by RBF, respectively. Results:chronic HD patients. We conclude that the use of ultrapure water for
l-NMMA dose-dependently increased MAP and SVR and decreaseddialysate clearly improves the biocompatibility of our HD treatments.
CI (p,0.001). NIF and ENA decreased basal MAP and potentiated
l-NMMA-induced systemic vasoconstriction (p,0.01). L-NMMA also
dose-dependently increased RVR and decreased RBF (p,0.001), butPlasma renin and prorenin and renin gene variation in patients with
neither drug potentiated these effects. Conclusions: These results indi-IDDM and nephropathy. J. Deinum, L. Tarnow, F. Derkx, M. Schale-
kamp and H.-H. Parving, Department of Internal Medicine I, Erasmus
University, Rotterdam, The Netherlands, Steno Diabetes Centre, Gen- OFF NIF ENA
tofte, Denmark. Although the most striking abnormalities in the renin-
daytime MAP mm Hg 12865 11664d 11566dangiotensin system (RAS) in diabetic nephropathy (DN) are increased
DMAP mm Hg 1562a 11362b,d 1962b,dplasma prorenin and possibly decreased renin, the renin gene has not
DCI l/min/m2 20.660.1b 20.860.2b 20.860.2b,cbeen studied for contribution to DN. We studied plasma renin, prorenin
DSVR mm Hg·min·m2/l 18.661.4b 114.662.0b,d 115.162.1b,dand four polymorphic markers of the renin gene in 199 patients with
DRBF ml/min 2328638b 2372639b 2327631bIDDM, complicated by both macroalbuminuria and retinopathy, and
DRVR mm Hg·min/L 178610b 17166b 17367b192 normoalbuminuric controls matched for age, sex and duration of
diabetes. Plasma renin and total renin were measured by immunoradio- Mean6sem, Significant change at dose III: ap,0.05, bp,0.001 from baseline;
cp,0.05, dp,0.01 vs. OFF.metric assay. Plasma renin was increased in patients with nephropathy
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cate that, in essential hypertensives, antihypertensive therapy with cutting the biopsy to maximize the detection of FN in clinical practice:
by using 2 series of 5 trichrome-stained sections, and skipping 15either NIF or ENA increases NO dependency of systemic vascular
tone, which may play a role in the blood pressure lowering effect of sections in between the other stainings, the chance to find FN is 78%.
these drugs. However, this phenomenon cannot be observed in the
renal circulation, suggesting a different regulation of endothelium-
dependent vasomotion in the hypertensive kidney. Inherited transient decorin deficiency during mesangial immune injury
is associated with persistent mesangial sclerosis. E. De Heer, D. Brees,
E.C. Bergijk, J.J. Baelde, A.M. van der Wal, J.A. Bruijn, W. Border,
N. Noble. Dept. Of Pathology, Leiden University Hospital, Div. ofIcodextrin with nitroprusside increases ultrafiltration and peritoneal
transport during long CAPD dwells. C.E. Douma, J.K. Hiralall, D.R. Nephrology, Salt Lake City, University of Utah. Administration of
anti-Thy-1 antibodies to rats leads to an acute mesangioproliferativede Waart, D.G. Struijk, R.T. Krediet. Academic Medical Center, Amster-
dam, The Netherlands. Addition of the nitric oxide (NO) donor nitro- glomerulopathy called anti-Thy-1 nephritis (ATN). ATN is character-
ized by an influx of inflammatory cells, followed by mesangiolysis,prusside to 1.36% glucose dialysate enlarges the effective peritoneal
mesangial proliferation and mesangial sclerosis. Previous studies insurface area during 4-hr dwells. The theoretical positive effect on
this model have shown that the fibrogenic cytokine TGF-b1 and itsultrafiltration is however counteracted by an increase in glucose absorp-
natural antagonist decorin play a key role in the initiation and thetion. The absorption of the glucose polymer icodextrin is much lower
termination respectively of the fibrotic reaction of the injured mesan-compared to glucose dialysate, due to its high molecular weight. In
gial cells. In most rat strains like in Wistar rats the fibrotic reactionthe present study 7.5% icodextrin with and without addition of 4.5 mg/L
in the glomeruli is transient and self limiting within 4 weeks. By contrastnitroprusside was studied during 8-hr CAPD dwells. Two standard
in LEW/Maa (LEW) rats administration of a single dose of anti-Thy-1peritoneal permeability analyses, adapted for 8-hr dwells, were per-
antibodies lead to persistent mesangial sclerosis for at least 6 months.formed in 10 stable CAPD patients. Nitrate and cGMP were measured
In this study we investigated whether differences in the TGF-b1 and theas parameters of NO synthesis. The transcapillary ultrafiltration in-
decorin response between Wistar en LEW rats would be responsible forcreased in a linear way with icodextrin (ICO) and was even higher
this strain-related difference. For this purpose ATN was induced inafter the addition of nitroprusside (NP): 666 (ICO) vs 834 (NP) mL/
these two inbred rat strains and the tissue repair reaction was monitored8hrs, P50.03. The effective lymphatic absorption rate was not different.
during the first three weeks after disease induction. From each individ-The resulting net ultrafiltration increased with nitroprusside: 344 (ICO)
ual rat the glomeruli were isolated, the extracted RNA was subjectedvs 540 (NP) mL/8hrs, p,0.01. The mass transfer area coefficient of urea
to competitive rt-PCR, or Northern analysis to quantitate the transcrip-increased 15% and of creatinine 26% with nitroprusside, consistent with
tion levels for TGF-b1, decorin and the ECM component fibronectinthe expected enlargement of the vascular surface area. The increase in
(Fn). These findings were compared to corresponding protein expres-protein clearances was more pronounced the larger the protein: b2-
sion and mesangial matrix expansion in these strains by (immuno)histo-microglobulin 19%, albumin 47%, IgG 63% and a2-macroglobulin
chemistry. LEW rats were shown to be transiently decorin mRNA95%. D/P ratios of nitrate were not higher than expected values on
deficient at d.1 after induction of ATN. At d.1 decorin protein wasthe basis of its molecular weight (P,0.001). They increased 19% with
absent in the mesangial matrix and gradually reappeared thereafter.nitroprusside. Also the D/P ratio cGMP after 4 hours increased with
In addition, LEW rats showed significantly raised and sustained TGF-nitroprusside: 0.39, range 0.13–0.55 (ICO) and 0.82, range 0.36–1.39
b1 mRNA (2-fold at d.1, 4-fold at d.7, still 2-fold at d.21) and protein(NP), P50.01. With nitroprusside the D/P ratio cGMP was higher than
expression, an abundant mRNA level (120-fold at d.7) and proteinexpected after 4 and 8 hrs, P,0.001. This points to local generation
accumulation of Fn, and persistent mesangial sclerosis. Wistar ratsof NO after addition of nitroprusside. The nitroprusside induced in-
developed increased mRNA level for TGF-b1 (3.5-fold at d.1, 4 foldcrease in the MTAC of creatinine and in the ultrafiltration caused an
at d.7). At d.21 the mRNA level for these transcripts had returnedincrease in the creatinine clearance from 4.2 mL/min to 5.0 mL/min.
to normal levels. In Wistar rats decorin protein immediately (d.1)This means that daily administration of nitroprusside will add 3 liter/
accumulated in the mesangial matrix. Fn mRNA was raised signifi-week to the peritoneal clearance of creatinine. The adequacy of perito-
cantly (70-fold at d.7), but only transient protein accumulation and noneal dialysis can therefore be improved by the addition of nitroprusside
persistent sclerosis was observed. This study supports the hypothesisto 7.5% icodextrin, used for the long exchange.
that the genetically inherited inability to counteract TGF-b1-induced
fibrosis by decorin leads to progressive accumulation of ECM.
Distribution of active renal lesions in Wegener’s Granulomatosis: a
3-dimensional analysis of 87 glomeruli. H.A. Hauer, I.M. Bajema, E.
Mannose 6-phosphate receptor-mediated internalization and activationde Heer, J. Hermans, E.C. Hagen and J.A. Bruijn. Departments of
of prorenin by cultured neonatal rat cardiac myocytes and fibroblasts.Pathology and Medical Statistics, Leiden University Hospital, Leiden C.A.M. van Kesteren, A.H.J. Danser, F.H.M. Derkx, J.M.J. Lamers,and Department of Internal Medicine, Eemland Hospital, Amersfoort, P.R. Saxena, M.A.D.H. Schalekamp. Cardiovascular Research Institute
The Netherlands. Extracapillary proliferation (EP) and fibrinoid necro- COEUR, Erasmus University Rotterdam, The Netherlands. The binding
sis (FN) are the main glomerular lesions in renal biopsies of patients and internalization of recombinant human renin and prorenin (2500
with Wegener’s Granulomatosis (WG). By means of a 3-dimensional mU/mL), and the activation of prorenin were studied in cardiac cells,
analysis we investigated the topographical features of these lesions to cultured in a chemically defined medium. Cardiac myocytes bound
determine the number of sections from a renal biopsy that should be renin and prorenin at 378C and 48C and the increase in cell-associated
evaluated in standard clinical practice in order to minimize the chance enzyme over time was similar for renin and prorenin, reaching a maxi-
of missing the lesion. Paraffin blocks of renal biopsies from 9 patients mum after 2–4 hours. Internalization which was determined with the
diagnosed with WG were completely cut up in 1 mm sections, and acid-wash method, occurred at 378C and not at 48C. At 378C, following
stained with the trichrome method according to Gomori. All sections incubation at 48C for two hours, 60–70% of surface-bound renin and
were evaluated by 2 observers. Glomeruli were scored on the presence prorenin was internalized within 5 minutes. Intracellular prorenin was
of FN, EP, and sclerosis. In absence of these lesions, they were scored activated but extracellular prorenin was not. The halftime of activation
as normal. Subsequently, a 3-dimensional reconstruction was obtained was 25 minutes. Binding of renin and prorenin to the cell membrane
for a total number of 87 glomeruli. In only one glomerulus FN was were inhibited by mannose 6-phosphate in a dose-dependent manner
detected without EP. In 51%, a combination of the two lesions was (IC50 5 100mM). Monensin (10mM) and NH4Cl (50 mM), which inter-
found, whereas in 22% EP without FN was scored. 26% was either fere with the normal trafficking and recycling of internalized receptors
normal or globally sclerotic. The fact that FN rarely occurs in the and ligands, inhibited prorenin activation but not its binding to the
absence of EP, may imply that these lesions are etiologically related. cell surface. Results obtained with cardiac fibroblasts were comparable
Taking the mean percentages of FN and EP in the number of glomeruli to those in the myocytes. This study is the first to demonstrate internal-
in a single section from all patients, we found 19% FN and 38% EP. ization and activation of prorenin by extrarenal cells via a mannose
After 3-dimensional analysis, however, these percentages increased to 6-phosphate receptor-dependent process. Our findings may have physi-
43% and 60%, respectively. Using a graphic 3-dimensional reconstruc- ological significance in light of the growing evidence that angiotensin
II is produced at cardiac and other extrarenal tissue sites by the actiontion of each biopsy we were able to define the optimal strategy of
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of renal renin and that intracellular angiotensin II can elicit important hour of the insulin infusion, CNa/GFR decreased 29.7% in sickle cell
physiologic responses. patients and 34.0% in healthy subjects (p,0.01) compared to the time-
control experiment. Conclusions: Insulin induces renal vasodilatation,
and sodium reabsorption beyond the long loops of Henle. Low-dose
Drug delivery of captopril results in selective inhibition of the renal ANP exerts a natriuretic effect along the long loops of Henle, but does
ACE. R.J. Kok, F. Grijpstra, F. Moolenaar, D. de Zeeuw, D.K.F. Meijer. not abolish insulin’s antinatriuretic effects.
GIDS, University of Groningen, the Netherlands. ACE inhibitors re-
duce urinary protein excretion in renal disease and exert a long-term
renoprotective effect. It is yet unknown whether these effects are a Reduced binding of immunoglobulin A (IgA) from patients with IgA
result of local tissue ACE inhibition or of a reduction of angiotensin nephropathy, to the myeloid IgA FC receptor, CD89. G. van Zandber-
II in the circulation. In order to establish the role of the local renal gen, C. van Kooten, N. Klar Mohamad, T.J.F. Reterink, J.W. de Fijter,renin-angiotensin system, we attempt to deliver the ACE inhibitor J.G.J. van de Winkel and M.R. Daha. Dept. of Nephrology, Leidencaptopril to the kidneys. Renal drug delivery can be achieved by the
University Medical Center, Leiden, Dept. of Immunology, Universitycoupling of drugs to the lower molecular weight protein (LMWP)
Hospital Utrecht, The Netherlands. Primary IgA nephropathy (IgAN)lysozyme. We designed a captopril-lysozyme conjugate (cap-LZM) in
is associated with elevated levels of circulating IgA and is characterizedwhich the ACE inhibitor captopril is coupled covalently to lysozyme
by deposition of primarily IgA1 in the renal mesangium. It has notvia a disulfide bond at a 1:1 molar ratio. In a pharmacokinetic study
been clarified yet which mechanisms govern the deposition of IgA1we showed that this drug conjugate was cleared from the blood similar
in the mesangium. One of the factors which may play a role in trappingto the native LMWP. In this study we present data on the efficacy of
of IgA in the mesangial area is the interaction of IgA with specificthe captopril lysozyme conjugate. Male Wistar rats received a single
IgA receptors (FcaR, CD89) on the mesangial cells. In vitro it hasbolus dose intravenously of either glucose 5% (control), captopril-
been reported that these cells express mRNA for CD89. In the presentlysozyme conjugate (equivalent to 0.2 mg/kg captopril) or free captopril
study IgA derived from patients with IgAN and controls was investi-and lysozyme. After distinct time intervals the rats were sacrificed
gated for its interaction with human CD89, that was expressed on theupon which the ACE activity was determined in plasma and tissue
surface of the murine B cell line IIA1.6. When purified IgA fromhomogenates of the kidneys. The inhibition of ACE was expressed as
myeloma patients or healthy individuals was incubated with CD89percentage of the ACE activity in the control experiment at t50 min.
Administration of the cap-LZM conjugate resulted in a reduced plasma expressing cells, a dose dependent binding of monomeric (m), dimeric
ACE inhibition (p,0.05). The renal ACE inhibition of the two treat- (d) and polymeric (p) IgA to these cells was found. The binding of
ments was equivalent at the first time points and averaged about 60%. dIgA and pIgA occurred in a more efficient fashion than that of mIgA.
From t560 min, the cap-LZM conjugate inhibited the renal ACE more In order to find out whether there was a difference in binding to CD89,
than free captopril (p,0.05). Since the conjugate itself did not inhibit of IgA directly from serum of patients or compared to controls, we
ACE in vitro, the conjugate must have been hydrolized and activated assessed the degree of binding to CD89-transfected IIA1.6 cells at a
in the kidneys. We compared the two captopril treatments by calculat- fixed dilution of serum. Although the patients had an increased level
ing the renal selectivity index (RSI) of renal ACE inhibition versus of IgA, no significant difference in binding was found. Therefore sera
plasma ACE inhibition. The RSI of the conjugate was 11.3 versus 1.5 from patients and controls were first fractionated by size and the
for free captopril at t530 min. We conclude that the renal selectivity fractions containing mIgA, dIgA or pIgA subsequently assessed for
of the ACE inhibitor is increased when the drug is targeted to the binding to CD89. Using these purified fractions a reduced binding ofkidneys. Therefore renal drug targeting by coupling of an ACE inhibi- mIgA from patients to CD89 was observed. The binding of IgA1tor to lysozyme via a degradable bond is a feasible approach to study
and IgA2 to CD89 was distributed equally, suggesting that CD89 onthe effects of local renal ACE inhibition.
mesangial cells may not be the only interaction which governs deposi-
tion of IgA in the kidney. These results suggest that additional, hitherto
unknown factors, may contribute to the initial trapping of IgA1 in theRenal effects of insulin and low-dose atrial natriuretic peptide in the
renal mesangium.long loops of Henle. J.C. ter Maaten, E.H. Serne´, L.W. Statius van Eps,
P.M. ter Wee, A.J.M. Donker, R.O.B. Gans.Dept. of Medicine, University
Hospital Vrije Universiteit, Amsterdam, The Netherlands. Insulin in-
duces sodium reabsorption at a distal tubular site. It is not clear whether Complement dependent regulation of apoptosis in anti-Thy.1 nephritis
sodium retention occurs along the long loops of Henle. It has been in rats. T. Sato, M.G.A. van Dixhoorn, F.A. Prins, A. Mooney, J.
suggested that low-dose atrial natriuretic peptide (ANP) induces natri- Savill and M.R. Daha. Dept. of Nephrology, Leiden University Medical
uresis by increasing medullary blood flow, and abolishes insulin’s anti- Center, Leiden, The Netherlands. Mesangial cell injury is a characteristic
natriuretic effects. We assessed the effects of insulin and ANP on renal observation in the early phase of Thy.1 nephritis. In the present study,
hemodynamics, using clearances of 131I-Hippuran and 125I-iothalamate, we investigated whether mesangial cell death by apoptosis occurs in
and sodium clearance in 8 patients with sickle cell disease, who are the early phase of Thy.1 nephritis using complement sufficient PVG/c
characterized by loss of the vasa recta and long loops of Henle, and (PVG/c1) rats and genetically complement C6 deficient (PVG/c2)8 matched healthy subjects. Studies were performed before and during rats. Further, using PVG/c2 rats supplemented with C6, the effect of4 h infusion of (1) insulin (50 mU/kg/h) using the euglycemic clamp
the terminal sequence of complement on in vivo apoptosis in thetechnique, 2 h infusion of (2) low-dose ANP (0.3 pmol/kg/h), (3) both
early phase of Thy.1 nephritis was examined. Apoptosis was analyzedinsulin and ANP, and (4) time-control experiments. Insulin-mediated
quantitatively in renal tissue sections both by counting condensedglucose disposal did not differ between both groups. During the fourth
nuclei following PAS staining (PAS method) and by the terminal
deoxynucleotide transferase method (TUNEL method). At 1 hour
Sickle cell patients Healthy subjects after injection of mouse anti-Thy.1 monoclonal antibodies (ER4G),
PVG/c1 rats exhibited 251 6 28 apoptotic cells/50 glomerular cross2nd hr 2nd hr
sections, whereas in PVG/c2 rats receiving ER4G only induced 8 6 2baseline (% change) baseline (% change)
apoptotic cells. In control rats receiving PBS no detectable apoptosis was
RBF (ml/min) observed. In immunofluorescence studies, intraglomerular deposition of
insulin 8556291 15.5 7896132 116.1b rat C6 and C5b-9 were only observed in PVG/c1 rats receiving ER4G.
ANP 8176253 21.4 7866123 23.2 Between 6 and 24 hours after the injection of ER4G, both types of
ANP1insulin 7856244 15.2 8026148 113.6bc rats exhibited clear apoptosis as compared to controls (p,0.01) for
time-control 8156268 21.2 7956118 21.4 PVG/C1 and PVG/c2 rats). Ultrastructural studies of renal tissue fur-
CNa/GFR % ther confirmed the presence of apoptosis in the early phase of Thy.1
insulin 1.5460.93 27.4 1.7060.58 227.4a nephritis. Mesangial cells were identified as the cells that underwent
ANP 1.2860.90 18.5 1.1660.42 131.9b apoptosis determined by double staining using the TUNEL method and
ANP1insulin 1.2760.43 19.4 1.3260.50 218.7c indirect immunofluorescence. These results in PVG/c1 and PVG/c2
time-control 1.2360.34 111.6 1.6660.54 11.9 rats suggest that a functional terminal sequence of complement strongly
ap,0.05, bp,0.01: vs time control; cp,0.001: ANP1insulin vs ANP enhances mesangial cell apoptosis. Further the results indicate that
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mesangial cell apoptosis may occur independent of the activation of (95% confidence interval (CI):3.2–7.8). The relative risks for infections,
cardiovascular disease and death are shown in the table.late complement components. To further investigate the role of the
terminal sequence of complement in mesangial cell apoptosis we as-
sessed apoptosis in PVG/c2 rats supplemented with two different RR 95% CI
doses of C6 and subsequently injected with ER4G. At 1 hour after
Infectionsthe injection of ER4G, PVG/c2 rats supplemented with C6 showed Viral 7.2 3.6–14.5
clear deposition of C6 in glomeruli and exhibited apoptosis to a similar Bacterial 3.3 2.5–4.3
degree as observed in complement sufficient PVG/C1 rats. These Sepsis 6.2 3.7–10.5
results, to our knowledge for the first time, demonstrate that the termi- Opportunistic 30.0 10.2–87.9
nal sequence of complement plays crucial role in mesangiolysis via the All infections 4.5 3.6–5.7
apoptosis pathway. Infectious mortality 5.0 3.2–7.8
Cardiovascular disease 3.7 1.8–7.8
Overall mortality 3.6 2.3–5.7
Nitro-L-arginine (NLA) increases efficacy of renal blood flow (RBF)
The increase in serious and life-threatening infections, as well as theautoregulation (AR) in normal and two-kidney, one-clip hypertensive
increased cardiovascular morbidity and overall mortality support therats. Erika Turkstra, Branko Braam, and Hein A. Koomans. Dept.
discontinuation of immunosuppressive drugs as soon as possible afterNephrology and Hypertension, University Utrecht, The Netherlands.
transplant failure. If discontinuation is not possible, removal of a failedIncreases in renal perfusion pressure (RPP) will induce shear-stress renal allograft should be considered.
mediated nitric oxide (NO) release, which could oppose autoregulation
of RBF. While cardiac, cerebral, and mesenteric AR is enhanced during
NO inhibition, this has not been reported for AR of RBF. To study 5-Methyltetrahydrofolate, the active form of folic acid, restores endo-
if NO inhibition enhances RBF AR, autoregulation was assessed in thelial dysfunction. M.C. Verhaar, R.M.F. Wever, J.J.P. Kastelein, T.
normal kidneys (CON, n56) and in non-clipped kidneys of 2K1C van Dam, H.A. Koomans, T.J. Rabelink. Dept. of Nephrology & Hyper-
Sprague-Dawley rats (3 weeks; 0.25 mm silver clip; n57). In the non- tension and Clinical Chemistry, University Hospital Utrecht and Dept.
clipped kidney, RBF AR is impaired, which could be due to increased of Vascular Medicine, Academic Medical Centre Amsterdam. Abnor-
malities in folate metabolism and folate deficiency have been associatedNO production (Sigmon, JASN 1994:1369) and stronger effects of
with increased cardiovascular risk and may contribute to the increasedNLA on AR were anticipated. AR was assessed prior to and during
cardiovascular risk in renal failure. The negative association betweeninfusion of the NO synthase inhibitor NLA (10 mg/kg/min i.v.) using
folate status and cardiovascular risk may, in part, be explained by thea transonic flowprobe around the renal artery. A sling around the
role of folates in homocysteine metabolism. In addition, folates haveaorta between the renal arteries was used to adjust RPP. The table
recently been suggested to stimulate endogenous regeneration of tetra-shows means arterial pressure (MAP), RBF, renal vascular resistance
hydrobiopterin (BH4), an essential co-factor for nitric oxide (NO)(RVR), the lower limit of autoregulation (LL-AR) and the autoregula-
production. The present study aimed to investigate whether folatestory index of the curves at 100 mmHg RPP (Index 100) under baseline might improve NO availability in vivo in patients with impaired NO
(Base) conditions and during NLA infusion (NLA): activity but normal homocysteine levels and without overt vascular
damage. We therefore studied the effects of administration of 5-methyl-
CON 2K1C tetrahydrofolate (5-MTHF, the active circulating form of folate) on
NO-bioavailability in 10 patients with familial hypercholesterolaemia,
Base NLA Base NLA as a model of endothelial dysfunction, and 10 matched controls by
venous occlusion plethysmography, using serotonin and nitroprussideMAP mm Hg 12264 151641 15166* 17465*1
as endothelium-dependent and independent vasodilators. In vitro, weRBF ml/min·g 8.260.9 4.760.51 6.260.9* 3.460.8*1
investigated the effect of 5-MTHF on NO-production by recombinantRVR units 1662 34631 2864* 76618*1
endothelial NO-synthase (eNOS), using 3H-arginine to 3H-citrullineIndex 100 units 0.10260.135 0.04660.013 0.59060.076 0.23260.093
conversion. We also studied the effects of 5-MTHF on superoxide-LL-AR mm Hg 7764 6762 8563 69651
generation by eNOS and xanthine-oxidase (XO), using lucigenin en-1 and *, p,0.05 vs. Base and CON, respectively
hanced chemiluminescence. Our in vivo experiments demonstrate that
the impairment of endothelium-dependent vasodilation in hypercho-Concluding, NO inhibition 1) strongly decreases RBF in the non-
lesterolemia (63% vs 90% in controls) can be reversed by co-infusionclipped kidney, 2) decreases the autoregulatory index of the curve, 3)
of 5-MTHF (117% vasodilation), whereas 5-MTHF has no significant
decreases the lower limit of AR in 2K1C rats. The study indicates effect on endothelium-dependent vasodilation in controls. 5-MTHF
that perfusion pressure-dependent NO-release can oppose AR in the does not influence basal forearm vasomotion or endothelium-indepen-
kidney. dent vasodilation. 5-MTHF has no direct effect on in vitro NO-produc-
tion by eNOS. However, there is a dose-dependent reduction in both
eNOS- and XO-induced superoxide-generation. These results show that
the active form of folic acid restores in vivo NO availability in hypercho-Increased complications after renal allograft failure with low-dose
lesterolemia. It is suggested from our in vitro experiments that thismaintenance immunosuppression. P.J.H. Smak Gregoor, R. Zietse,
effect is due to reduced catabolism of NO. Our findings call for furtherJ.L.C.M. v Saase, C.T. op de Hoek, A.T. Lavrijssen, G.M.Th. de Jong,
studies to assess the clinical value of oral folic acid therapy as a novelW. Weimar. Dept. of Nephrology: University Hospital Rotterdam-Dijk-
tool to reduce cardiovascular risk in, for example, renal failure.zigt, St.Clara and St.Franciscus Gasthuis Rotterdam, Oosterschelde Hos-
pital Goes, Drechtsteden Dordrecht, the Netherlands. After renal allo-
graft failure, immunosuppressive therapy is often continued when the Albumin stimulation of endothelin production by proximal tubular
failed renal allograft is left in place. Although, whenever feasible, it epithelial cells (P’TEC) is mediated by advanced glycation end-products
is usually tapered to a low maintenance dose. We compared morbidity (AGE) receptors. B.A. Yard, E. Chorianopoulos, F.J. van der Woude.
and mortality between patients with (group A) or without (group B) V. Medizinische Klinik, University of Heidelberg, Klinikum Mannheim,
low-dose immunosuppression. In a multi-centre hospital based cohort Mannheim. In patients with diabetic nephropathy, renal endothelin
study we analyzed data from patient files. We evaluated 257 patients (ET) production is increased (Sharmak et al, Diabetes 1997, 46:854).
who received 326 kidney transplantations between 1971 and 1996. A Moreover it has been demonstrated that ET transgenic rats develop
total of 2.04 vs. 0.45 infections/patient-year were found in groups A interstitial fibrosis without hypertension (Hocker et al, J Clin Inv,
and B, respectively. A total of 28 lethal infections were found in group 1997,99:1380). In the present study we therefore questioned, which
factors (CsA, Ang II, glucose, albumin and heparin) may influenceA, opposed to 13 lethal infections in group B, relative risk (RR) 5.0
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the production of ET by human PTEC and by which receptors this be useful to identify predictors for long term renal function loss. To
this purpose we analysed the course of renal function after LTx in 23was mediated. Endothelin production was measured by a specific RIA
for ET-1 and ET-2. CsA, glucose and Ang II did not influence ET-1/2 patients (14M/9F) with a follow up of at least 30 months (mean 6 SD;
44 6 11). GFR was measured before LTx, at 1 month and subsequentlyproduction. Heparin, however inhibited ET release by PTEC in a dose
dependent fashion. This inhibition was most likely due to binding and every 6 months after LTx. This allowed accurate calculation of the
rate of renal function loss for individual patients.was dependent on the degree of N-sulfation of heparin. In contrast to
CsA, Ang II and glucose, BSA was able to upregulate ET production
in a time and dose dependent fashion. Since part of the BSA is normally GFR mean
glycosilated, upregulation of ET production may be mediated by the Time (range) ml/min % change
receptor for advanced glycation end-products (RAGE). The RAGE
pre-Tx 107 (74;163)binding b-amyloid peptide strongly enhanced ET production, thereby
month 1 80 (39;146) 225 (263;13) vs. pre-valuedemonstrating that triggering of this receptor is able to influence ET
month 30 55 (19;104) 232 (280;111) vs. month 1production. Furthermore it was shown that AGE-albumin was much
more potent in the upregulation of ET production than non-glycosi-
After LTx renal function impairment occurred in all patients, with alated albumin tested at equimolar concentrations. In order to demon-
large between-patient variability. The mean rate of GFR decline fromstrate more directly that albumin stimulation of ET production is
6 months onwards was 29 ml/min/yr, with a range from 20.4 to 222.8mediated by RAGE, antisense RAGE oligonucleotides were added
ml/min/yr. Two predictors of a poor long term renal outcome couldto PTEC prior to BSA stimulation. Addition of these constructs to
be identified. These were pulmonary diagnosis and the severity ofPTEC completely abolished the BSA upregulation of ET production.
perioperative renal function loss irrespective of diagnosis (p,0.005).In conclusion we demonstrate that BSA induced tubular ET production
In patients with pulmonary hypertension (n53) the slope of GFR (ml/is mediated by RAGE. These findings suggest that intra-renal AGE
min/yr) decline (mean 21.8, range 20.4 to 22.4) was significantlyreceptors are relevant for the progression of renal insufficiency in the
better than in emphysema patients (n516, mean 28.1, range 20.9 toproteinuric state.
216.7). In cystic fibrosis patients (n54), however, the slope of GFR
decline was significantly worse (mean 217.8, range 210.2 to 222.8).
This could be due to differences in treatment regimen, such as antibioticCellular localisation of Polycystin-1 and Polycystin-2. D.J.M. Peters,
use or to pre-existing patient characteristics. Thus, renal function lossM. Scheffers, L. Spruit, P. v.d. Bent, J.A. Bruijn, M.H. Breuning, E.
is a major clinical problem after LTx. Patients with CF are at a particu-de Heer. Dept. of Human Genetics, Leiden University, The Netherlands,
larly high renal risk. In addition, irrespective of pulmonary diagnosis,Dept. of Pathology, Leiden University, The Netherlands. The PKD1 and
the extent of perioperative renal function loss provides an early markerPKD2-gene, mutated in patients with Autosomal Dominant Polycystic
of a poor long term renal prognosis. These findings could guide theKidney Disease, encode novel proteins (Polycystin-1 and Polycystin-2)
development of prevention strategies for this high risk population.with unknown functions. Based on computer analysis Polycystin-1 is
predicted to play a role in cell-cell or cell-matrix interactions while
polycystin-2 shows homology with a class of voltage activated sodium
The role of alloantigen-independent factors in chronic rejection ofand calcium channels. Polyclonal antibodies have been raised against
renal transplants. E.A. Kouwenhoven, U.W. Heemann, F. Bonthuis,several synthetic peptides and fusion proteins corresponding to frag-
R.L. Marquet, J.N.M. IJzermans, R.W.F. de Bruin; Dept of Surgery,ments of both proteins. With the obtained antisera several cultured
Erasmus University, Rotterdam, The Netherlands; Dept. of Nephrology,cell lines have been analysed by immunofluorescence and confocal laser
University Hospital, Essen, Germany. Chronic rejection (CR) is thescanning microscopy. In cyst-lining epithelial cells and in fibroblasts
major cause of late renal graft loss. Although acute rejection appearedobtained from a skin biopsy and from chorion villi, a fine punctate
to be a main risk factor for CR, it is still a matter of debate whethercytoplasmic staining pattern was seen upon analysis with antibodies
alloantigen-independent factors contribute to this process as well. Theagainst Polycystin-1. In addition several cells show intense staining in
aim of this study was to elucidate the influence of 2 alloantigen-indepen-the cellular extensions at the site of interaction with adjacent cells. In
dent factors, namely 1) surgical procedure and 2) cold ischemia onMadin Darby Canine Kidney (MDCK) cells, a tubular epithelial cell
the development of CR in a rat kidney transplantation model. Renalline forming a confluent monolayer in culture, antibodies against fusion
isografts were compared to allografts and unilateral nefrectomizedproteins encoding fragments of exon 5, 15, and exon 46 of Polycystin-
(UNX) rats. Syngeneic transplantations were performed between in-1 showed intense staining at the site of interaction between adjacent
bred BN rats, and allogeneic from BN to WAG rats, treated for 3cells. Staining is observed as a fine interrupted line along the entire cell
weeks with CsA. The grafts were preserved at 48C in UW-solution.membrane. No signal was detected at the free borders of aggregates. In
Two cold ischemia times (0.1 versus 24 h) were studied. Glomerularaddition some cytoplasmic staining was observed which increased at
filtration rate/100 gr body weight (GFR, ml/min) and albuminuriahigher cell-densities. Antibodies against exons 4-6 and exons 11-15 of
(UaV, mg/24 h) were determined monthly. Systolic blood pressurePolycystin-2 showed variation in intensity and localisation. Sometimes
(SBP, mm Hg) was measured at graft retrieval. Histomorphologicala weak signal at the site of interaction between adjacent cells was seen
analysis according to the BANFF criteria was performed. Isograftsand sometimes a very intense signal at points of interaction between
and UNX were killed 52 weeks post-transplantation; allografts wereseveral neighbouring cells was detected. In addition cytoplasmic stain- sacrificed at week 22 because of end stage graft failure.ing was observed. Analysis of Polycystin-1 in two-colour immunofluo-
rescence performed with antibodies against Zona Occludens (ZO-1),
Donor-recipient n SBP GFR UaV BANFFE Cadherin, and Desmoplakin I1II recognising tight junctions, ad-
herens junctions and desmosomes respectively, suggested co-localisa- BN-WAG 6 13064 0.3060.04 131660 7.360.7
tion with Desmoplakin I1II but not with ZO-1 and E-Cadherin. Our BN-BN, 24 h ischemia 6 12362 0.3860.04 105629 4.360.7
data suggest that Polycystin-1 plays a role in cell-cell interactions via BN-BN 5 11461 0.4360.03 961.7 2.660.2
its interaction with the desmosomal junctional complex. BN UNX 8 11761 0.4260.01 960.9 2.760.3
Allograft function deteriorated rapidly due to CR, involving severe
A poor long term renal outcome after lung transplantation is predicted glomerular and tubulo-interstitial changes, and only minor intimal prolif-
by pulmonary diagnosis and by perioperative renal function loss. J. eration. In contrast, isografts with a minimal ischemic time and UNX
Broekroelofs, G.J. Navis, C.A. Stegeman, W.J. de Boer, W. van der Bij, did not show significant functional and histological changes during the
D. de Zeeuw, P.E. de Jong. Department of Internal Medicine, University 1-year observation period, suggesting that the surgical procedure per se
Hospital Groningen, The Netherlands. Unfortunately, renal function does not contribute to CR. However, 24 h cold ischemia led to a slow
loss is common after solid organ transplantation. We previously re- progressive decline: UaV and BANFF were significantly increased at
ported considerable renal function impairment after lung transplanta- week 52 compared to isografts. Thus, 1) BN kidney is susceptible to
tion (LTx). Both perioperative renal damage and long term cyclosporin CR in an allogeneic environment, 2) surgical procedure alone does
not enhance CR and 3) Cold ischemia is a potent risk factor for CR.treatment could play a role. To design prevention strategies, it would
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Blocking of costimulatory pathways using monoclonal antibodies to subclinical infection or ciclosporin toxicity. As these receptors buffer
the bioavailability of TNF-a, they may contribute to the immunosup-prevent transplant rejection in a non-human primate model. M. Osse-
voort, J. Ringers, L. Boon, K. Lorre´, M. de Boer, M. Jonker, A. Van pressive state after kidney transplantation.
de Voorde, Biomedical Primate Research Centre, Rijswijk, Department
of Surgery, University Hospital Leiden, Leiden, Pangenetics, Amster-
dam, Innogenetics, Gent, Belgium. The optimal therapy to prevent Race and kidney transplant-survival. J.I. Roodnat, R. Zietse, J. Rischen-
Vos, T. van Gelder, J.N.M. IJzermans, W. Weimar.Department of Internalgraft rejection should be based on the induction of specific non-respon-
siveness to the donor tissue. Current concepts hold that non-respon- Medicin I and General Surgery, University Hospital Rotterdam-Dijkzigt,
Rotterdam, The Netherlands. Most studies on the influence of acceptorsiveness or so-called anergy is the result of intracellular signalling after
T cell receptor/Major Histocompatibility Complex (MHC)-peptide in- race on kidney transplant-survival have been performed in the U.S.A.
Generally they show a lower survival in African-Americans comparedteraction (signal 1) in the absence of a co-stimulatory signal (signal 2).
There is accumulating evidence that blocking the costimulatory path- to Caucasians. Potential explanations are: more HLA-mismatches,
worse socio-economic circumstances and hypertension in the African-ways, such as CD80/CD86-CD28/CTLA4 and CD40L-CD40 offers a
valid approach for immune suppression after solid organ transplanta- American population in combination with a predominantly Caucasian
kidney donor supply (ca 90%). As Rotterdam has become a multi-tion. Blocking both CD80 and CD86 using CTLA4-Ig or a combination
of anti-CD80 and anti-CD86 monoclonal antibodies (mAb) results in ethnic society we were able to study the kidney-survival in different
races in all 1013 transplantations that were carried out in our centerprolongation of allograft survival in rat and mouse transplantation
models. The additional blockade of the CD40-CD40L pathway has between 30-5-’71 and 17-1-’96. The population was restricted to recipi-
ents of a primary cadaveric graft. Patients were divided into two mainbeen described to result in prolongation of allograft survival and even
to induce allograft tolerance. These promising data initiated this study groups according to origin: group 1 5 European (N5607), group 2 5
non-European (N5118). Five subgroups of group 2 were defined: Afri-to explore the use of anti-CD80 and anti-CD86 mAb in combination
with anti-CD40 mAb as a prophylactic treatment to prevent solid organ can, Asian, Chinese, Arabian and Turkish. Kidney-survival was defined
as surviving with a functioning kidney transplant and was comparedtransplant rejection in a pre-clinical life-supporting kidney transplant
model in rhesus monkeys. The kidney function was monitored by serum with the Kaplan Meier analysis, followed by the log-rank test. The
mean age and sex-distribution were not different, as was the totalcreatinine. The mean survival time of untreated kidney-transplanted
rhesus monkeys is 6 days. Prophylactic short term (14 day) treatment number of (known) HLA-mismatches. The non-Europeans appeared
to have more often hypertension and less often hereditary diseases aswith either anti-CD80 plus CD86 mAb alone or in combination with
anti-CD40 mAb resulted in prolonged graft survival (19–35 days). their original disease. Bloodgroup B was more and bloodgroup A was
less prevalent among non-Europeans. The causes of death and theDuring the treatment period, no signs of side-effects or rejection were
noted. Kidney graft rejection started after the antibody therapy was causes of transplant failure were not different between the Europeans
and the non-Europeans. There was no significant difference in kidney-stopped. The induction of the anti-antibody response was significantly
delayed using these antibody combinations as compared to the treat- survival between the groups 1 and 2 (p50.97) and between group 1 and
the individual subgroups. Most non-Europeans have been transplantedment using anti-CD80 alone or other immunosuppressive murine
monoclonal antibodies such as anti-CD4, demonstrating a significant after 1982, so they predominantly had cyclosporine as primary immuno-
suppression. No significant differences appeared between the Europe-effect on the B-cell response as well. Thus, prolonged graft survival
times can be achieved by blocking the costimulatory pathways in pre- ans (N5360) and the non-Europeans (N590) in the cyclosporin treated
population (p50.74). We conclude that in our center Europeans andclinical vascularized transplant model in rhesus monkeys.
non-Europeans have equal chances after kidney transplantation.
TNF-a: mRNA, plasma protein levels and soluble receptors after suc-
cessful kidney transplantation. I.C. van Riemsdijk, C.J. Hesse, R. Zietse, Immunological risk factors of chronic transplant dysfunction are domi-
nant. Y.W.J. Sijpkens, M.J.M. Mallat, A.H. Zwinderman, R.G.J. Wes-E.H.M. Loonen, C.C. Baan, W. Weimar. Dept. of Internal Medicine I,
University Hospital Rotterdam-Dijkzigt, Rotterdam, The Netherlands. tendorp, F.J. van Kemenade, J.A. Bruijn, J.W. de Fijter, L.A. van Es,
Leiden University Medical Centre. Introduction. Chronic transplantTNF-a is a pro-inflammatory cytokine, whose bioavailability is regu-
lated by 2 membrane receptors, p55 and p75. Their extracellular dysfunction (CTD) is the most important obstacle for long-term graft
survival. Clinically, chronic transplant dysfunction is defined as a grad-splitproducts can be detected as soluble forms in the circulation: sTNF-
R1(p55) and sTNF-R2(p75). In end-stage renal failure and during ual decline in renal function, typically occurring months or years after
transplantation and eventually leading to graft loss. The pathogenesishemodialysis sTNF-R levels are significantly higher (sTNF-R1:10-15
vs 0.7; sTNF-R2:15-22 vs 1.6 ng/ml). In 16 patients (9 male, 7 female, is still not well understood. Both immunological and no-immunological
factors may play a role. We studied the impact of all relevant recipient,age 22–55 yrs) who received a living-related kidney transplantation,
we measured mRNA expression in PBMC, plasma TNF-a and the donor and transplantation characteristics on graft loss due to CTD.
Patients and methods. Between 1983 and 1997 almost one thousandsTNF-receptors daily, during the first postoperative week (ELISA,
R&D Systems Europe, Abingdon, UK), as well as sTNF-receptor kidney transplants were performed in the Leiden University Medical
Centre. All patients with a functional transplant and follow-up beyondexcretion in urine. The creatinin clearance improved from ,5 ml/min
to 60 ml/min. Concentrations of sTNF-receptors decreased rapidly in six months after transplantation were evaluated. Immunological and
non-immunological risk factors of graft loss due to CTD were tested24 hours and stabilized at 3.1 ng/ml (sTNF-R1) and 4.7 ng/ml (sTNF-
R2). Both concentrations are still significantly higher compared to in uni- and multivariate analyses using the Cox model. Results. 757
kidney transplants (657 cadaver and 100 living donors) performed inhealthy controls (p50.0003). Fractional clearance for sTNF-R1 was
9% and for sTNF-R2 even 5%. TNF-a mRNA-expression by PBMC 717 patients were studied. There were 126 retransplantations. Follow-
up varied from 6 months to 14 years (mean 5,5 years). A total of 221before and after transplantation was not different compared to controls.
To evaluate the influence of immunosuppressive therapy we measured grafts were lost; 90 (41%) due to CTD, 13 (6%) due to de novo or
recurrent glomerulonephritis and 114 (52%) due to patient death within stable kidney transplant recipients, more than 1 year after trans-
plantation, TNF-a and the sTNF-receptors in plasma and urine. In a functioning transplant. Independent risk factors of graft failure due
to CTD were the following; young recipient age (p,0.0002), pre-CsA-treated patients (n57, creatinin 135 mmol/l) plasma concentration
sTNF-R1 was 3.2 ng/ml and sTNF-R2 5.8 ng/ml. In Aza-treated patients transplant panel reactive antibodies (p50.0121), pre-transplant dia-
stolic blood pressure (p50.00621), number of acute rejection episodes(n57, creatinin 115 mmol/l) the levels were 3.2 ng/ml (sTNF-R1) and
4.0 ng/ml (sTNF-R2), p50.04. Fractional clearances were 2% for both (p,0.00001), qualitative proteinuria (p,0.00001) and serum creatinine
(p,0.00001) at 6 months after transplantation. Conclusion. In patientssTNF-R1 and sTNF-R2 in both groups. The decrease of sTNF-receptor
concentrations can only partially be explained by renal clearance and with graft loss due to CTD immunological risk factors were strongly
dominant. Young recipients with panel reactive antibodies, more thanmay be due to a decreased production as a result of the abrogation
of the uremic state. However, the persistent elevated levels of these one acute rejection episode and impaired renal function with protein-
uria at six months post-transplantation have the greatest risk of latereceptors after kidney transplantation are not the result of activation
of the TNF-a system, but may be caused by allogeneic reactivity, graft loss.
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Cyclosporin changes the pharmacokinetics of mycophenolate mofetil an important component of many basement membranes throughout
the body. Six genetically distinct a-chains are known, forming triplein kidney transplant recipients. P.J.H. Smak Gregoor, C.J. Hesse, B.J.
van der Mast, J.N.M. IJzermans, W. Weimar, T. van Gelder. Dept. of helical structures. TATA-less bidirectional promotors located in be-
tween the a1(IV) and a2(IV) genes and in between the a3(IV) andInternal Medicine I and Surgery, University Hospital Rotterdam, The
Netherlands. Cyclosporin (CsA) and prednisone (pred) with a standard a4(IV) genes regulate transcription. Regulatory sequences embedded
in the a1(IV) first intron modulate a1(IV) and a2(IV) transcription.dose of 2 grams mycophenolate mofetil (MMF) results in a 50% reduc-
tion of the incidence of acute rejection after kidney transplantation. The a3(IV) and a4(IV) collagen chains have a distinct cell- and tissue-
specific localization, and the mechanisms regulating the expression ofWhether mycophenolic acid (MPA) monitoring leads to a further im-
provement of clinical outcome is unknown at present. MPA is avidly these genes are poorly understood. The a1/a2(IV) and a3/a4(IV)
promotors share little homology. Therefore, it is possible that thebound to human serum albumin. Some drugs (furosemide, salicylate)
affect MPA binding and result in higher free fraction. Cholestyramine differential expression of these genes in tissues is determined by the
promotor sequences. To test this hypothesis we transfected NIH3T3and antacids, decrease the bioavailability of MMF. CsA is supposed
not to interact with MMF. However, MPA concentrations in patients fibroblasts and HR9 carcoma cells with constructs containing the a1/
a2 and a3/a4 promotor with or without the a1(IV) first intron enhancertreated with the combination of CsA 1 MMF 1 pred have been found
to be lower than in patients treated with FK506 1 MMF 1 pred. This directing the transcription of the luciferase reporter gene. HR9 cells
normally produce high amounts of a1(IV) and a2(IV) and low amountshas been contributed to an interaction between FK506 and the MMF/
MPA pharmacokinetics. To study the effect of CsA on MPA pharmaco- of a3(IV) and a4(IV) collagen. NIH3T3 cells have low collagen IV
transcription and served as negative controls. Transfection with thekinetics we measured MPA concentrations in blood samples from
kidney transplant patients treated with CsA 1 MMF 1 pred (n 5 141 promotor-luciferase construct alone was not able to activate the lucifer-
ase gene, indicating a role for regulatory sequences outside the promo-samples from 25 patients) or with MMF 1 pred (n 5 74 samples from
16 patients). All MPA concentrations were measured using the EMIT tor region. In HR9 cells, but not in NIH3T3 cells, the luciferase activities
increased in the presence of the a1(IV) first intron enhancer (20-foldMPA Assay. Blood samples were taken after an overnight fast and 12
hours after the last dose. MPA pre-dose concentrations were signifi- for the a1, a2, and a4 promotors and 10-fold for a3). This suggests
that the machinery of the HR9 cell, in the presence of the a1(IV) firstcantly lower in patients treated with CsA compared to the group
without CsA (mean 1.44 mg/l vs 4.17 mg/l; median 1.34 mg/l vs 3.62 intron enhancer, was able to modulate the a3/a4(IV) promotor. We
conclude that the a3/a4(IV) collagen promotor by itself does not ac-mg/l; p-value , 0.0001 Mann Whitney). No significant differences be-
tween the two groups existed in respect to age, sex and body weight. count for the unique cell- and tissue-specific expression of these genes.
It is likely that additional elements flanking the promotor modulateIn conclusion, we demonstrate for the first time that pre-dose MPA
concentrations in kidney transplant recipients treated with CsA are its expression in a developmentally regulated and cell- and tissue-
specific fashion.significantly lower than in patients treated with MMF and pred only.
These data strongly suggest that CsA affects the pharmacokinetics of
MPA. Key word: transplantation
IL-4 and IL-13 augment cytokine-induced and CD40-induced RANTES
production by human renal tubular epithelial cells in vitro. J.G.M.
Deckers, S. de Haij, F.J. Van der Woude, S.W. Van der Kooij, C. VanComparison of renal histopathology in anti-Pr3 and anti-MPO systemic
vasculitis. I.M. Bajema, E.C. Hagen, J. Hermans, L.H. Noe¨l, R. Wald- Kooten, M.R. Daha. Department of Nephrology, Leiden University
Hospital, Leiden, The Netherlands. Local production of cytokines byherr, F. Ferrario, F.J. van der Woude, and J.A. Bruijn, for the EC/
BCR Project for ANCA-Assay Standardisation. Depts. of Pathology, infiltrating monocytes, macrophages, Th1 and Th2 cells is important
in renal allograft rejection. Activated Th1 cells can produce IL-2, IFN-gNephrology, and Medical Statistics, Leiden University and Leiden Uni-
versity Hospital, the Netherlands; Eemland Hospital, Amersfoort, the and TNF-a while Th2 cells produce IL-4, Il-10 and IL-13, that inhibit
Th1 cells. Furthermore, activated T cells express the costimulatoryNetherlands. Dept. of Nephrology, Hopital Necker, Paris, France; Dept.
of Pathology, Univ. of Heidelberg, Germany; Dept. of Nephrology, molecule CD40-ligand. During renal allograft rejection the chemokine
RANTES is detected in both infiltrating mononuclear cells, and tubularOspedale San Carlo Borromeo, Milan, Italy; Vth Med. Dept. Med.
Faculty Mannheim, Germany. Within the systemic vasculitides, a dis- epithelium. We have shown previously that stimulation of proximal
tubular epithelial cells (PTEC) with cytokines or CD40-ligand resultstinction can be made between patients based on the antigen-specificity
of their anti-neutrophil cytoplasmic antibodies (ANCA). A cANCA in production of RANTES. In the present study we investigated the
influence of Th1 and Th2 cytokines on RANTES production by acti-pattern at IIF is associated with anti-Pr3 antibodies, and a pANCA
pattern with anti-MPO antibodies. If and how these immunological vated PTEC. RANTES was not detectable in supernatants of human
PTEC stimulated with IL-2, IL-4, IL-10 or IL-13 alone. Likewise,findings reflect upon the histopathology of the kidney, is still unknown.
In a multi-center European trial, 161 renal biopsies were obtained from combination of these cytokines with IL-1a, IFN-g or TNF-a, respec-
tively, did not result in detectable RANTES production. IL-2 and IL-patients with systemic vasculitis, and they were evaluated according to
a standardized scoring protocol. ANCA specificity was determined by 10 had no detectable effect on RANTES production by activated
PTEC. IL-4 or IL-13 in combination with IL-1a1IFN-g or IFN-g1IFF and by ELISA. 49 patients had a cANCA at IFF with anti-Pr3
antibodies, 59 a pANCA with anti-MPO antibodies. 20 were negative TNF-a resulted in a two- to four-fold augmentation (ranging from
2.260.2 to 2562 ng/ml in different cell lines) of RANTES production.on both tests, and in 33 the IIF test results were not in line with the
ELISA. There were no differences between groups in the occurrence CD40-activated PTEC stimulated with IL-4 or IL-13 produced six to
ten times more RANTES (ranging from 7.961.9 to 6263.5 ng/ml inof cellular or fibrous crescents, fibrinoid necrosis, and interstitial or
periglomerular granulomas. Minor differences were found in the occur- different cell lines) compared to CD40-activated cells alone. Since
RANTES production is augmented by IL-4 and IL-13, we suggest thatrence of global glomerular sclerosis (p50.03), mesangial proliferation
and matrix increase (p50.02, p50.01), focal and diffuse interstitial during rejection by direct cellular contact between activated T cells
and tubular epithelial cells amplification of the local inflammatoryinfiltrates (p,0.05 and p50.02), interstitial fibrosis (p50.04), and arte-
riosclerosis (p50.03). All these lesions were more frequently present reaction in the kidney may occur, resulting in deterioration of graft
function. Keyword: transplantatiein anti-MPO patients. However, after correction with the Bonferroni
formula, none of these values proved to be statistically significant. We
therefore conclude that despite their immunological variability, the
Co-deposition of polymeric rat IgA together with IgG aggravates renalrenal histopathology among patients with systemic vasculitis is to a
injury in rats. M.G.A. van Dixhoorn, T. Sato, D. van Gijlswijk-Janssen,large extent the same.
Y. Muizert and M.R. Daha. Department of Nephrology, Leiden Univer-
sity Medical Center, Leiden, The Netherlands. Primary IgA Nephropa-
thy (IgAN) is the most prevalent immunologically mediated form ofPromotor-flanking sequences modulate transcription regulation of col-
lagen type IV genes. E.C. Bergijk, M. van Griensven, E. de Heer, glomerulonephritis. IgAN is characterized by activation of complement
(C), mesangial cell proliferation, hematuria and proteinuria. In patientsJ.A. Bruijn, #P.D. Killen. Depts. of Pathology, Univ. of Leiden, The
Netherlands, and #Univ. of Michigan, Ann Arbor, MI. Collagen IV is a more progressive form of disease correlates with co-deposition of
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IgA together with IgG. We developed a reproducible experimental resulted in strong synergistic effects on the production of IL-6, IL-8
and RANTES. Up to 100-fold increase in cytokine production wasmodel of IgAN in rats (Stad, R.K. et al. Clin. Exp. Immunol. 92:514–521,
1993). In the present study we investigated the effect of the co-deposi- observed after this combined activation. No synergy was observed
between CD40L and IL-2, IL-4, IL-10, TNFa or IFNg. Similar stimula-tion of polymeric IgA and IgG on glomerular injury. Administration
of a suboptimal dose of rat IgG2a anti-DNP (50 mg / rat) antibodies tory effects were obtained for IL-1 alpha and IL-1 beta. Effects of
IL-1 were dose- and time- dependent, and were blocked by IL-1RA.alone to rats did not induce abnormal proteinuria (max. 20.3 6 13.1
mg/24 hrs) on day 2 after injection (n56), nor glomerular C activation Interestingly, IL-1RA also reduced production of cytokines by IL-17-
stimulated PTEC, suggesting the endogenous production of IL-1 byor influx of inflammatory cells. Similarly, injection of a suboptimal
dose of 5 mg of polymeric rat IgA anti-DNP antibodies to rats alone PTEC. This was confirmed by RT-PCR analysis, which showed the
expression of both IL-1 alpha and IL-1 beta mRNA. In conclusion,resulted in 61.4 6 24.5 (mg/24 hrs) on day 2 after injection (n56).
Glomerular complement activation up to the C3 stage and a moderate we have demonstrated that combined signaling of IL1 and CD40L
leads to a strong synergistic activation of PTEC and these signals mightinflux of inflammatory cells was observed. When the combination of
IgG2a- and polymeric IgA anti-DNP was injected, an increase in pro- therefore contribute to the local inflammatory response. keyword: Im-
munologieteinuria was observed (74.2 6 13.1 mg/24 hrs) on day 2, but this was
not significantly different from rats injected with antibodies alone.
However, whereas no deposition of C6 was observed in kidneys of
rats treated with single antibody injections, a distinct diffuse, mesangial Biodistribution of Polycystin-1. D.J.M. Peters, A. v.d. Wal, L. Spruit,
M.H. Breuning, E. de Heer, J.A. Bruijn. Dept. of Human Genetics anddeposition of C6 was found in glomeruli of the combination group.
Single antibody injections induced only minor histological changes, Dept. of Pathology, Leiden University, The Netherlands. Autosomal
Dominant Polycystic Kidney Disease is mainly characterised by thebut the combination resulted in a pronounced, significantly increased
formation of glomerular aneurysms on day 7 after injection (p,0.05). formation of fluid-filled cysts in both kidneys. In addition extra-renal
manifestations can occur including cysts in other organs (e.g. liver,We conclude that co-deposition of IgG together with IgA in this experi-
mental model for IgAN aggravates renal inflammation. spleen, pancreas), colonic diverticulae, hypertension, cardiac valve ab-
normalities and intracranial aneurysms. The PKD1-gene, mutated in
85% of ADPKD-patients encodes a novel protein with a putative
role in cell-cell/cell-matrix interactions and cellsignalling. PolyclonalExpression of TIMP-1 mRNA is upregulated in renal fibrotic areas
after cyclosporine (CsA) treatment. Carla Duymelinck*, Jing-Ti Deng*, antibodies were raised against peptides and fusionproteins correspond-
ing to Polycystin-1 in order to get more insight in the function of theGert Verpooten* and Marc De Broe, University of Antwerp, Department
Nephrology, Antwerp, Belgium. Chronic CsA-induced nephropathy is protein. Polyclonal antibodies against exons 24 and 46 have previously
been shown to stain nephronic epithelia in normal fetal and adulthistologically characterized by tubular lesions, focal interstitial fibrosis
(IF), interstitial recruitment of inflammatory cells and arteriolopathy. kidneys as well as the cyst-lining epithelium in cystic kidneys. Now
these antibodies have been used to study the expression of Polycystin-1Recent studies show that the inhibition of matrix degradation in the
kidney plays a pivotal role in the development of renal IF. We examined in a large number of paraffin-embedded tissues by immunoperoxidase
staining. Expression has been seen in tissues with a known manifesta-the expression of components of the metalloproteinase (MMP) system
in kidneys from rats injected daily s.c. with CsA (10, 15 or 20 mg CsA/ tion of the disease (liver, pancreas, lung, ovaries, colon, duodenum,
cardiac valves, cerebral arteries) and in tissues of organs which seemkg bw) or vehicle-solution. In all CsA-treated rats, serum creatinine
levels were significantly increased compared to controls. Semi-quanti- not to be affected (skin, salivary glands). Expression was mainly seen
in epithelia and frequently in epithelia lining excretory ducts but alsotative analysis of histopathological lesions revealed tubular lesions and
IF in all groups receiving CsA. Interstitial collagenase and stromelysine in endocrine cells (pancreatic Beta-cells, parathyroid producing cells,
Leydig cells). In addition expression was observed in myocard andtranscripts were not increased after CsA treatment. In contrast, tissue
inhibitor of MP (TIMP) expression was significantly increased after more weakly in myocytes of cardiac valves and of cerebral arteries.
Staining in myocytes of cardiac valves and cerebral arteries could beCsA treatment. In situ hybridization (ISH) of a renal section from a
rat treated with 15 mg CsA/kg bw during 5 weeks and injected with enhanced by trypsin treatment. We conclude that in concordance with
the systemic nature of the disease, Polycystin-1 is expressed in manyLPS 2 hours before sacrifice identified the cells responsible for the
increased TIMP mRNA levels, as parietal epithelial cells, glomerular tissues. The expression pattern suggests a role for Polycystin-1 in trans-
porting epithelia and tissues which are subjected to increased mechani-cells and interstitial cells in fibrotic areas. No ISH signals for TIMP-1
were found in kidneys from control rats. ISH of control rat renal tissue cal pressure.
with a tPA RNA probe revealed transcripts in glomerular cells. This
was confirmed in immunohistochemical stainings, where tPA antigen
Differential agrin expression in renal basement membranes as revealedwas also present in vasa recta. Using ISH, no change in the amount
by domain-specific monoclonal antibodies. C.J.I. Raats, M.A.H. Bak-of tPA message was found after CsA treatment. These results indicate
ker, W. Hoch, W.P.M. Tamboer, A.J.A. Groffen, L.P.W.J. van denthat the locally increased expression of inhibitors of matrix degradation
Heuvel, J.H.M. Berden and J. van den Born. Division of Nephrology(TIMP-1) in the kidney rather than a suppressed expression of MMP,
and Department of Pediatrics, University Hospital St. Radboud, Nij-contributes to the development of CsA-induced focal IF in the rat.
megen, The Netherlands and Department of Biochemistry, Max Planck
Institute of Developmental Biology, Tu¨bingen, Germany. Heparan sul-
fate proteoglycans (HSPG) are thought to be important for the perm-Synergistic effect of IL-1 and CD40L on the activation of tubular
epithelial cells. C. van Kooten, X. van der Linde, L.A. van Es, M.R. selective properties of the glomerular basement membrane (GBM).
In the present study, we evaluated the HSPG specificity of two hamsterDaha. Department of Nephrology, Leiden University Medical Center,
Leiden, the Netherlands. Previous studies have demonstrated that prox- monoclonal antibodies (mAbs) against rat glomerular HSPG. They
were characterized by ELISA on various BM components, immuno-imal tubular epithelial cells (PTEC), are a central cell type in renal
inflammation and activation with IL-1 leads to the production of vari- fluorescence on rat kidney cryostat sections, and by immunoprecipita-
tion with rat glomerular HSPG with or without heparitinase pre-treat-ous inflammatory mediators. Recently we demonstrated that cultured
PTEC express a functional CD40 receptor. Crosslinking of this receptor ment. These experiments showed that the antibodies specifically
recognize the core protein of rat glomerular HSPG. However, thehas stimulatory effects on the production of both cytokines (IL-6,
TNFa) and chemokines (IL-8, MCP-1, RANTES). In the present study identity of this HSPG has not been resolved yet. Besides the well-
known BM HSPG perlecan, another BM component, named agrin,we investigated the effect of combined signaling via IL-1 and CD40L.
Primary cultures of human PTEC were established from normal kidney was recently identified as an HSPG. Agrin is found in the basal lamina
of the neuromuscular junction, in BMs of many tissues and we showedtissue specimens. PTEC were activated by recombinant IL-1, CD40-
ligand or combinations, and the activation products IL-6, IL-8, MCP-1 that agrin is present in the GBM as well (Groffen et al., J Histochem
Cytochem 1997, in press). On kidney cryostat sections, the hamsterand RANTES were measured by specific ELISA. Activation of PTEC
by IL-1 resulted in enhanced production of IL-6, IL-8 and MCP-1, but mAbs stained in a linear way the GBM and, with less intensity, the
tubular basement membranes (TBMs). This staining pattern differednot of RANTES. Simultaneous activation of PTEC by IL-1 and CD40L
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from the staining of an antiserum against perlecan, which stained pre-
FN-Region Model EIIIA EIIIB TGF-bdominantly the TBM and the mesangium, but the GBM to a lesser
extent. These observations led us to hypothesize that our mAbs recog- GvHD 2 2 2
nize agrin. Therefore, we evaluated by FACS analysis staining of chi- CSS 1 1 1
nese hamster ovary (CHO) cells transfected with various constructs ATN 1 1 1
coding for full length agrin or parts of the agrin molecule. Both hamster
mAbs clearly stained CHO cells transfected with the construct coding The FN transcripts in GVHD mice showed exclusion of the EIIIA
for full length agrin whereas untransfected cells and cells transfected and EIIIB regions. This was in contrast with the splice variants found
with the construct coding for the C-terminal half of agrin were not in ATN and CSS in rats. Here FN mRNA had included both the EIIIA
recognized, indicating that both hamster mAbs recognize (an) epi- and EIIIB regions by alternative splicing. In conclusion this study
tope(s) on the N-terminal half of agrin. On rat kidney cryostat sections, supports our earlier postulated hypothesis that the development of
six mAbs directed against well-defined domains in the C-terminal half glomerulosclerosis in GvHD is TGF-b independent.
of agrin stained predominantly the GBM whereas most of the TBMs
lacked any staining. This contrasts our hamster mAbs which, besides
to the GBM recognized all TBM. Based on these results, we hypothe- The role of the cell adhesion molecule CD11b/CD18 in rat experimen-
size that in the GBM predominantly full length agrin is expressed, tal anti-Thy-1.1 glomerulonephritis. R. Westerhuis, M.G.A. van Dix-
whereas in the TBM (besides perlecan) predominantly a truncated hoorn, C.D. Dijkstra, T. Sato, E. de Heer & M.R. Daha. Department
isoform of agrin is expressed which misses (part of) the C-terminal half, of Nephrology and Pathology, University Hospital Leiden, University
possibly due to alternative splicing or posttranslational modifications. Leiden, Leiden, the Netherlands. The integrin CD11b/CD18 has been
shown to be linked to the influx of macrophages in different reperfusion
models in rabbit, experimental allergic encephalomyelitis or acute coli-
A spectrum of mutations in the second gene for autosomal dominant tis in rats. To investigate the role of CD11b/CD18 during experimental
polycystic kidney disease. B. Veldhuisen, J.J. Saris, S. de Hay, S. Somlo, anti-Thy-1.1 glomerulonephritis, with a maximum of macrophage influx
M. Breuning and D. Peters. Department of Human Genetics, Sylvius on day one, we treated wistar rats before and 3 days after induction
Laboratory, Leiden University, The Netherlands. Division of Nephrol- of nephritis with 0,5 mg ED7. ED7 is a monoclonal antibody directed
ogy, Albert Einstein College of Medicine, New York, USA. Autosomal against rat integrin CD11b/CD18 also known as the type three comple-
Dominant Polycystic Kidney Disease (ADPKD) is one of the most ment receptor (CR3). In this study we demonstrate by immunohisto-
frequently inherited disorders, with an incidence of 1 in 1000 individu- chemical staining that ED7 is able to reduce the influx of macrophages
als. The disease is mainly characterized by the formation and enlarge- on day 3 (p,0,05) and PMN (polymorphonuclear leukocytes) until
ment of multiple cysts in both kidneys which can lead to renal failure day 6 after the injection of the anti-Thy-1.1 antibody. Furthermore on
in adults. In most of the families with ADPKD the disease is caused day 6 and 10 after induction of nephritis we observed a significant
by a mutation in the PKD1 gene, located on chromosome 16p13.3. higher degree of hematuria in ED7-treated rats as compared with those
The gene product, polycystin-1, is thought to be involved in cell/cell injected with PBS (p,0,01). Further on day 3 we observed a significant
higher degree of aneurysmatic glomeruli. However, the developmentor cell/matrix interactions. In about 15% of the ADPKD families, the
of proteinuria and matrix accumulation were not reduced during anti-mutation responsible for the disease is linked to the PKD2 gene on
Thy-1.1 glomerulonephritis by ED7 treatment. We conclude that mac-chromosome 4q21-22. Recently this gene has been cloned. It encodes
rophage- and PMN influx in rats with glomerulonephritis induced byfor a putative integral membrane protein, polycystin-2, which shows
monoclonal mouse anti-Thy-1.1 antibody does not result in reductionamino acid similarity to polycystin-1 and to the family of voltage-
of proteinuria. At later time points than day 1, there was a significantactivated calcium (and sodium) channels. We have screened the PKD2
reduction of macrophages and PMN’s in the glomerulus of ED7-treatedgene for mutations by Single-Strand Conformation-Polymorphism
animals but still associated with hematuria and aneurysm formation,Analysis (SSCA) and the Protein Truncation Test (PTT) in 39 families
suggesting that other factors than macrophages and PMN play a morewith the second type of ADPKD and identified 25 mutations. In addi-
pronounced role in this disease. These findings may be of importancetion to alterations leading to a premature translation stop, two amino
to understand the pathogenetic role of CD11b/CD18 and macrophages/acid substitutions and five possible splice mutations have been found.
PMN during nephritis.So far, most mutations found seem to be unique and occur throughout
the gene. For both the PKD1 and PKD2 gene, truncating mutations
have been identified, resulting in a loss of a large part of the protein.
Increased glomerular capillary pressure in fawn-hooded hypertensiveThese findings suggest that ADPKD is caused by the loss of at least
(FHH) rats due to impaired autoregulation of renal blood flow. R.P.E.one functional copy of the gene. Recently, a ‘second hit’, a somatic
Van Dokkum, H.J. Jacob, A.P. Provoost, and R.J. Roman, Departmentmutation in the normal copy of the PKD1 gene has been detected in
of Pediatric Surgery, Erasmus University, Rotterdam, The Netherlands,cyst lining cells. Whether the second hit is the initial step towards cyst
and Department of Physiology, Medical College of Wisconsin, Milwau-formation and whether this phenomenon also occurs in PKD2 cysts
kee, WI, U.S.A. Responses to changes in renal perfusion pressure (RPP)has to be elucidated.
were compared in hypertensive (FHH) and normotensive (FHL) fawn-
hooded and ACI rats to determine whether impaired autoregulation
of renal blood flow (RBF) contributes to the elevation in glomerular
Alternatively spliced isoforms of fibronectin mRNA in experimental capillary pressure (Pgc) and the develoment of proteinuria and glomer-
immune complex glomerulonephritis. A.I. van Vliet, J.J. Baelde, E.C. ular damage in the FHH strain. RBF was measured using an electro-
Bergijk, E. De Heer, J.A. Bruijn. Department of Pathology, Leiden magnetic flowmeter and Pgc was assessed by measuring proximal tubu-
University Hospital, The Netherlands. Glomerulosclerosis is a severe lar stop-flow pressure at RPP’s of 100, 125, and 150 mm Hg. RPP was
complication of many immunologically mediated kidney diseases. Fibro- elevated by tying off the mesenteric and celiac arteries and lowered
nectin (FN) is one of the main ECM-components in sclerotic lesions. using an aortic occluder. Baseline RBF was significantly higher in FHH
Accumulation of FN can occur both by local qualitatively altered tran- (n 5 9) compared to FHL (n 5 10) and ACI (n 5 9) and averaged
scription and by accumulation from the circulation. Cytokine-induced 9.660.7, 7.460.5, and 7.860.9 ml/min per gram kidney weight at RPP’s
alternative mRNA splicing of the FN gene is responsible for the expres- of 14762, 13262, and 12364 mm Hg, respectively. RBF was autoregu-
sion of various FN isoforms. The fibrogenic cytokine TGF-b induces lated in ACI and FHL, but not in FHH rats. Autoregulatory indices
the inclusion of the EIIIA and EIIIB regions. In this study we investi- in the range of pressures from 125 to 150 mm Hg averaged 0.9660.12
gated the splicing patterns of these regions in various experimental in FHH, 0.4260.04 in FHL, and 0.3060.02 in ACI rats respectively,
glomerulopathies. RT-PCR analysis was performed using RNA ex- GFR was also significantly higher by 20–30% in FHH than in FHL
tracted from the glomeruli of mice with chronic graft-versus-host dis- and ACI rats at every RPP studied. Elevation of RPP from 100 to 150
ease (GvHD), rats with chronic serum sickness (CSS) and rats with mm Hg increased Pgc in FHH rats (n 5 9) from 4661 to 7162 mm
anti-Thy-1 nephritis (ATN). The observed FN-isoforms were corre- Hg, whereas it only increased from 3962 to 5361 mm Hg in FHL rats
(n 5 6). The present data indicate that autoregulation of RBF islated with the expression of TGF-beta during the course of disease.
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impaired in FHH rats, leading to elevation of Pgc, hyperfiltration, roids significantly different in the groups with or without NC. Conclu-
proteinuria and subsequent development of glomerulosclerosis. The sion: NC can be found in approximately 40% of premature infants 4
mechanism responsible for these phenomena remains to be deter- weeks after birth and in 50% at term. Urinary calcium/creatinine 4
mined, but is either due to lack of tubuloglomerular feedback or impair- weeks after birth and calcium/citrate ratios at term are significantly
ment of the myogenic response. (*p , 0.05) higher in preterm neonates with NC. Possibly vitamin D
intake plays a role in the pathogenesis of NC in preterm neonates. Of
the 14 preterm neonates with NC at term, 6 still had NC at the age
Genetic analysis of the susceptibility to renal damage after unilateral of 6 months. More children have to be included in the study and
nephrectomy in rats. A.P. Provoost, M. Shiozawa, R.R. Majewski, children with NC will be followed up at 1 and 2 years to further evaluate
R.P.E. Van Dokkum, and H.J. Jacob, Department of Pediatric Surgery, causes and prognosis of NC.
Erasmus University, Rotterdam, The Netherlands, and Department of
Physiology, Medical College of Wisconsin, Milwaukee, WI, U.S.A. We
have previously reported on the presence of two major genes, Rf-1 and Renal extraction of homocysteine and other amino acids in fasting
Rf-2, responsible for proteinuria (UPV) in a backcross of proteinuric man. C. van Guldener, A.J.M. Donker, C. Jakobs, T. Teerlink, K. de
hypertensive fawn-hooded (FHH) and normotensive non-proteinuric Meer, C.D.A. Stehouwer, Depts of Nephrology, Internal Medicine and
ACI rats. Interestingly, Rf-1 was independent of systolic blood pressure Clinical Chemistry, Academisch Ziekenhuis Vrije Universiteit and Insti-
(SBP). Here we wanted to extent these findings, investigating whether tute for Cardiovascular Research, Amsterdam, and University Children’sadditional genes were involved in the accelerated development of renal
Hospital, Utrecht, The Netherlands. Hyperhomocysteinemia occurs indamage after uninephrectomy (UNX). The male progeny (n 5 360)
end-stage renal disease (ESRD) patients and may contribute to theirof an F2 intercross between FHH and ACI rats was subjected to UNX
propensity to atherothrombotic disease. The pathophysiological mech-at 5 weeks of age. Phenotyping included determination of SBP and
anism of elevated plasma homocysteine levels in ESRD is obscure.UPV 8 weeks after UNX. The rats were then sacrificed and the inci-
Loss of urinary homocysteine clearance is unlikely as the amount ofdence of focal and segmental glomerulosclerosis (FGS%) assessed.
homocysteine in urine of healthy subjects is negligible. Loss of activeGenotyping was done in DNA derived from the spleen. A total of 336
homocysteine uptake, which has been demonstrated in the normal ratpolymorphic markers (SSLPs) covering 91% of the total rat genome
kidney by the finding of a substantial (20%) difference between arterialwere analyzed. Genetic linkage analysis was done using the MAP-
and renal venous plasma homocysteine, seems an attractive alternativeMAKER-QTL computer package. Analysis of the F2 intercross con-
explanation. In man, renal arteriovenous differences of several aminofirmed the presence of the two QTLs for UPV, Rf-1 and Rf-2 on rat
acids have been studied, but not of homocysteine. Normal kidneyschromosome 1, with LOD-scores amounting to 16.0 and 5.4, respec-
extract citrulline and generate serine and arginine. We measuredtively. Three additional QTLs linked with UPV, named Rf-3, Rf-4,
plasma total (i.e. free and protein-bound) homocysteine (tHcy), freeand Rf-5 were identified on chromosomes 3, 14, and 17, with LOD-
homocysteine (fHcy) and other amino acids sampled from the aortascores of 5.8, 4.1, and 2.9, respectively. All five Rf-loci also showed
(A) and renal vein (V) of 20 fasting patients with normal renal func-linkage with FGS%. Only one locus showed linkage with SBP, that is
tion (serum creatinine 90.5 6 SD, 15.6 mmol/l), who underwent elec-the previously identified QTL at the Rf-2 area on chromosome 1.
tive cardiac catheterisation. Arterial tHcy and fHcy were 10.8 6 3.1In conclusion, these findings firmly establish the importance of Rf-1
determining the susceptibility to renal damage. The discovery of three and 3.2 6 1.6 mmol/l, respectively. Renal extraction, calculated as
additional QTLs underscores the complexity of the genetics of progres- (A 2 V)*100%/A, was 0.9% (SD 5.8; 95%CI 21.8–13.6) for tHcy,
sive renal failure. and 20.2% (11.0; 25.4–14.9) for fHcy. As in other studies, significant
renal production of serine (RE – 45.6%) (15.9; 253.0–238.1) and
arginine (RE 216.6%) (5.6; 219.2–214.0) were demonstrated, as well
Nephrocalcinosis in preterm neonates. E.A. Feith, J.E. Kist-van Holthe, as net extraction of citrulline (RE 36.3%) (12.0; 30.7–42.0). We con-
H.N. Conneman, P.H.T. van Zwieten, S. Veen, H.M. Zonderland, H.C. clude that no significant net renal uptake of homocysteine occurs in
Holscher, R. Brand, A.J. van der Heijden, Department of Pediatrics, fasting humans with normal renal function and that elevated fasting
Academisch Ziekenhuis Leiden, the Netherlands. The incidence of homocysteine levels in patients with renal failure thus cannot be ex-
nephrocalcinosis (NC) in preterm neonates varies widely from 17–64%. plained by the loss of such extraction.
The causes are not yet elucidated. The aim of the study was to investi-
gate the incidence and causes of NC in preterm neonates. In a prospec-
tive pilotstudy conducted from 1-5 to 1-8-1996 28, 70% of all preterm An Aquaporin-2 water channel mutant which causes autosomal domi-
neonates with a gestational age # 32 weeks were investigated. Patient nant nephrogenic diabetes insipidus is retained in the Golgi complex.
characteristics and intake of calcium, protein, vitamin C, D, medication E.J. Kamsteeg, S.M. Mulders, D.G. Bichet, J.P.L. Rijss, M.F. Arthus,
etc were noted. Ultrasound of the kidneys was performed 4 weeks M. Lonergan, M. Fujiwara, K. Morgan, R. Leijendekker, p. van der
after birth, at term and at the age of six months. Serum creatinine was Sluijs, C.H. van Os en P.M.T. Deen. Mutations in the Aquaporin-2
used as an indicator of GFR. Excretion of calcium, oxalate and citrate (AQP2) water channel gene cause autosomal recessive nephrogenic
was measured in 8 h urine samples at 4 weeks and at term. The main diabetes insipidus (NDI). We here report a patient with an autosomal
results are given in table 1 as numbers of patients or means (sd). dominant form of NDI, which is caused by a G866A transition in the
AQP2 gene of one allele, resulting in a E258K substitution in the C-tail
dubious without of AQP2. To define the molecular cause of NDI in this patient, AQP2-
with NC NC NC E258K was studied in Xenopus oocytes. In contrast to wild-type AQP2,
AQP2-E258K confined a small increase in water permeability, causedNumber of patients
by a reduced expression at the plasma membrane. The physiologically-4 weeks after birth 8 5 7
important phosphorylation of S256 by protein kinase A was not af-at term 14 3 11
fected by the E258K mutation. Immunoblot and microscopic analysesGestational age weeks 29 2⁄7 28 5⁄7 29 5⁄7
revealed that AQP2-E258K was, in contrast to AQP2 mutants in reces-Birth weight grams 1269 (162) 1187 (314) 1336 (313)
sive NDI, not retarded in the endoplasmic reticulum, but retained inSerum creatinine lmol/l 36 (10) 42 (7) 42 (6)
the Golgi compartment. Because AQP2-R253*, which lacks the AQP2-Uca/creat mmol/mmol 3.33 (1.55)* 2.96 (1.36) 1.66 (0.37)
Uox/creat mmol/mmol 0.29 (0.13) 0.32 (0.20) 0.69 (0.45) tail, was only slightly impaired in its transport to the plasma membrane,
Uca/citr mmol/mmol 3.2 (3.6)* 1.3 (0.2) 1.0 (0.6) the E258K mutation presumably introduces a Golgi retention signal
instead of changing an existing AQP2 routing signal. Since AQPs are
thought to tetramerize, the retention of AQP2-E258K together withVitamin D intake in the third week after birth was significantly higher
wt AQP2 in mixed tetramers in the Golgi compartment is a likelyin prematures with NC compared to prematures without NC. There
explanation for the dominant inheritance of NDI in this patient. keywas no significant difference in the other laboratory parameters, nor
were mechanical ventilation days, the use of furosemide and corticoste- word: fysiologie
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Dissociation between the renal effects of angiotensin I and II in sodium- Normalisation of renal function decline in ischemic nephropathy. Long-
restricted normal subjects. M.M.E. Krekels, W. Spiering, N.C. Schaper, term outcome of surgical revascularisation. C.J. van Rooden, J.H. van
A.J.H.M. Houben, and P.W. de Leeuw, Dept. of Medicine, Maasland Bockel, G.G. De Backer, J. Hermans, P.C. Chang. Dept. of Nephrology,
Hospital, Sittard and Dept. of Medicine, University Hospital Maastricht, University Hospital Leiden, The Netherlands. Renovascular disease
The Netherlands. Aim: In the present study we compared the systemic may lead to ischemia of the nephrons and fibrosis, which is generally
and renal effects of equimolar doses of AngI and AngII, in order to considered to be irreversible and progressive. We investigated the
determine whether the effects of AngI can be fully explained by its potential of revascularization to recover and stabilize renal function
conversion into AngII in the plasma compartment. Methods: Ten healthy in patients with ischemic nephropathy. In a retrospective analysis of
male volunteers who were in balance on a sodium-restricted diet were all our 61 patients with ischemic nephropathy who were treated by
studied on two separate occasions during which, in random order, infu- surgical revascularization, we determined the long-term course of renal
sions of human AngI or AngII were given in stepwise increasing doses function decline, using estimated glomerular filtration rate (EGFR;of 0.3, 1 and 3 pmol/kg.min. Mean arterial pressure (MAP), heart rate, Cockcroft and Gault formula). Assuming normal renal function at ageeffective renal plasma flow (ERPF), glomerular filtration rate (GFR),
25 years, the preoperative slope of EGFR and the postoperative sloperenin (APRC), AngII, aldosterone (Aldo) and catecholamines were
of EGFR, were determined from the EGFR preoperatively, at short-assessed at baseline, after each dose of AngI or AngII and thirty and
term follow-up (on average 8 months postoperatively) and at long-termsixty minutes after discontinuation of the AngI/AngII infusion. Results:
follow-up (on average at 47 months postoperatively). These declines inAngII levels rose significantly less during the AngI infusion than during
renal function were compared to EGFR values in age- and sex-matchedthe AngII infusion (p,0.05). The increments in MAP and Aldo and
samples from a large cross-sectional population study. Overall surgicalthe decrease in GFR, however, were comparable during both the
mortality amounted to 13.1%. Five patients became dialysis dependent;infusion regimens. In the kidney, on the other hand, the fall in APRC
two with preexisting end-stage renal disease, three at later follow-up,and ERPF during the AngII infusion exceeded those during AngI
while two patients who preoperatively were dialysis-dependent could(p,0.05). After cessation of the AngI/AngII infusion, AngII concentra-
be withdrawn from dialysis treatment. Shortly after the operation thetions quickly returned to baseline as did MAP, ERPF and Aldo. Only
renin remained significantly inhibited (p,0.05). Catecholamines did mean EGFR level had increased from 28.3 to 43.1 ml/min/1.73m2
not change during any of the experiments. Conclusion: Our data suggest (p,0.01). From the preoperative slopes of renal function decline,
that the effects of AngI on blood pressure and aldosterone release 22.5160.20 ml/min/1.73m2/year (M6SEM), we estimated that our pa-
may be brought about by AngII, formed, at least partly, from the AngI tients would be in need of dialysis treatment, i.e. would reach an EGFR
at tissue sites. However, due to a low capacity of the kidney to convert of 10 ml/min/1.73m2, after 8.4 years. Postoperatively the slope had
AngI, the renal effects of AngI are less prominent than those of AngII. decreased to 21.0060.43 ml/min/1.73m2/year, equal to a slope of
The longer-lasting inhibition of renin after cessation of the AngI/ 21.1360.02 ml/min/1.73m2/year in the age and sexmatched control
AngII infusion points towards accumulation of AngII in the kidney population, and which was estimated to have delayed the time at which
or prolonged suppression of renin mRNA. dialysis treatment would be needed up till 17.8 years. In conclusion:
surgical revascularization in selected patients with renovascular disease
and ischemic nephropathy restores renal function and makes the aver-A prediction rule for renal artery stenosis as a guidance to renal
age long-term rate of decline in renal function equal to that in theangiography in drug-resistant hypertension. P. Krijnen, B.C. van Jaars-
general population, indicating that in most patients a ‘point-of-no-veld, E.W. Steyerberg, A.J. Man in ‘t Veld, J.D.F. Habbema. Center for
return’ had not yet been passed even though their renal function wasClinical Decision Sciences, Dept. of Public Health, and Dept. of Internal
markedly impaired preoperatively.Medicine, University Hospital Dijkzigt, Erasmus University Rotterdam,
The Netherlands. Renal angiography, the gold standard for diagnosing
renal artery stenosis, is a costly and invasive procedure. Because the
Renal vasoconstriction in respiratory failure is not a consequence ofprevalence of renal artery stenosis in the general hypertensive popula-
respiratory acidosis. Y.M. Vermeeren, W. van der Bij, R.G. Grevink,tion is low, angiography should be performed only in patient groups
with an increased probability of stenosis. As an alternative for non- P.E. de Jong, G.J. Navis. Divisions of Nephrology and Pulmonology,
invasive tests such as renal scintigraphy, that unfortunately have a low Department of Medicine, University Hospital, Groningen, The Nether-
diagnostic accuracy, we investigated the use of clinical characteristics lands. In respiratory failure renal vasoconstriction is often present. It
in the selection of patients for renal angiography. Data from the Dutch is thought to contribute to the sodium retention often present in this
Renal Artery STenosis Intervention Cooperative (‘DRASTIC’) study condition. The mechanism of this renal vasoconstriction is incompletely
have shown that drug-resistance to an antihypertensive two-drug regi- elucidated. Experimental data suggest an important role for hypercap-
men is an adequate first step in this selection process. As a following nic acidosis. To test this hypothesis we analyzed data on renal hemody-
step, we used data on clinical characteristics of 477 patients with drug- namics and acid base status of 39 patients with stable, severe respiratory
resistant hypertension who participated in the DRASTIC study, to failure due to COPD, referred to our center for lung transplantation.
develop a prediction rule for renal artery stenosis. Nine of these clinical The patients were grouped according to acid-base status. The groups
characteristics were selected as predictors for stenosis: age, gender, were similar in age, drug use, oxygenation and systemic and pulmonary
atherosclerotic vascular disease, time of onset of hypertension, smoking hemodynamics. Results: medians and 95% confidence intervals.
history, body mass index, an abdominal bruit, serum creatinine level
and serum cholesterol level. These characteristics were combined in
Range Respiratory Respiratory Metabolica logistic regression model predicting renal artery stenosis. To facilitate
its use in clinical practice, a scorechart was developed, which attributed healthy Neutral acidosis alkalosis alkalosis
a score to the presence or level of each clinical characteristic. After volunteers n512 n510 n510 n57
adding these scores into a sumscore, the corresponding probability of
pH 7.36–7.44 7.42 7.39 7.46 7.44stenosis could be read from a graph. The prediction rule discriminated
7.40–7.42 7.37–7.40 7.44–7.48 7.43–7.45well between patients with stenosis and those with essential hyperten-
pCO2 4.6–6.0 5.1 7.0 4.7 5.9sion (area under the ROC curve50.84), although atherosclerotic steno-
kPa 5.0–5.5 6.5–7.7 4.2–4.7 5.7–6.0sis was predicted somewhat better than fibromuscular dysplasia. This
HCO32 24228 26 31 24 30prediction rule offers a good compromise between performing angiog-
raphy in every patient (100% sensitivity) and performing angiography mmol/l 25–26 30–33 23–24 29–31
only in patients with an abnormal renal scan, which reduces the number GFR 94–134 96* 100 96* 80*
of angiograms by 75% but misses about 30% of the patients with ml/min 87–106 87–116 89–107 73–88
stenosis. If this prediction rule would be used to select patients for ERPF 391–775 338* 330* 316* 287*
angiography by performing angiography only in patients for whom the ml/min 298–363 274–399 300–344 245–362
rule predicts a probability of stenosis of, for instance, more than 10%, FF % 17–26 29* 32* 31* 28*
the number of angiograms would be reduced by 40%, whereas more 28–30 28–33 28–33 24–33
than 90% of the patients with stenosis would still be identified. We RVR 5–11 13* 14* 14* 16*
conclude that this prediction rule is a practical and cheap alternative dsc25 11–16 13–16 13–16 13–18for renal scintigraphy in the diagnostic management of hypertensive
patients. *p,0.001, compared to healthy volunteers
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Thus, a range of acid-base disturbances is encountered in stable patients by doppler-measurement. Cardiovascular disease was scored using a
standardised Rose-questionnaire and ECG registration. A 2-hour OGTTwith end stage respiratory failure. GFR was significantly decreased in
all groups, except in patients with respiratory acidosis. ERPF was below was performed with exception of those known to have diabetes. In
addition to univariate analysis, a syndrome-X score (SXS) was formu-normal in all groups. Accordingly, FF and RVR were increased in all
groups. Between the patient groups no significant differences in renal lated. SXS represented the number of syndrome-X related biochemical
(triglycerides .2.8 mmol/l, HDL ,0.91 in ? and ,1.17 mmol/l in /, totalhemodynamics were found. In conclusion these data do not support
the hypothesis that hypercapnic acidosis plays a key role in renal cholesterol .6.2 mmol/l, fasting insulin .19mU/l, impaired glucose
tolerance or diabetes), physiological (MAP .116 mmHg, cardiovascu-vasoconstriction in respiratory failure. Rather they suggest that renal
vasoconstriction is related to the state of respiratory failure per se. lar disease) and antropometric (BMI .25 in ? and .27 kg/m2 in /)
abnormalities and ranged from 0 to 8. Statistical analysis was performed
using Wilcoxon test. Univariate analysis revealed no significant differ-
ences of syndrome-X parameters between either groups. Also, noHyperfiltration in non-complicated IDDM is not related to metabolic
control, blood pressure, plasma volume or sodium-lithium counter- differences were found in SXS between parents of IDDM patients
with or without DNP. Subanalysis of categories (fathers/mothers oftransport. G. Vervoort, J.F.M. Wetzels, L. Elving, J.A. Lutterman, P.
Smits and J.H.M. Berden. Department of Internal Medicine and Ne- IDDM sons/daughters/offspring with or without DNP) revealed again
no differences. Conclusion: In this study parental syndrome-X featuresphrology, University Hospital St Radboud, Nijmegen, The Netherlands.
Intra-glomerular hypertension and hyperfiltration are dominant fea- have no discernible role in the development of DNP in offspring with
IDDM. Possible confounders may be that the parents were too youngtures in the pathogenesis of diabetic nephropathy in IDDM. The exact
pathogenesis of early hyperfiltration remains elusive. In IDDM patients (mean age 6267 yr) to have a complete expression of syndrome-X
features. Furthermore a selective participation could have occurredan increased sodium-lithium countertransport (Na-Li-CT) may be asso-
ciated with the development of diabetic nephropathy, and a relation among those initially invited to participate in our study. A non-partici-
pation study has been initiated, in order to clarify this matter.between an increased Na-Li-CT and early hyperfiltration has been
suggested. We have studied 54 non-complicated IDDM patients (DP)
and 50 healthy subjects (C) in whom renal function (GFR by measuring
renal clearance of inulin at glucose levels controlled between 5.0 and Air-free hemodialysis reduces clotting activation. R.J.R. Beijering,
R.W. van Olden, H. ten Cate, J.W. ten Cate, Departments of Vascular8.0 mmol/l), blood pressure (BP) intra-arterially, Na-Li-CT, plasma
volume and transcapillary escape of albumin (TERalb), basal urinary Medicine and Nephrology, Academic Medical Center, University of
Amsterdam, the Netherlands. In a cross-over study we determinedalbumin excretion rate (AER) and metabolic control (HbA1c) were
measured. Results are expressed as means 6 SE. Data were analysed the influence of air-free dialysis (Genius, NovaMed, Bad Homburg,
Germany) versus the usual air-containing (bubble and buffer chamber)by Student-t-test for Gaussian distribution and Mann-Whitney-U test
for non-normally distributed data. GFR was significantly increased in dialysis (AK 100, Gambro BV, Breda, the Netherlands) on coagulation
and fibrinolysis in three patients on chronic intermittent hemodialysis.DP (GFR was 12062 in DP and 10662 ml/min/1.73m2 in C, P,0.01).
GFR of 130 ml/min/1.73m2 was the upper limit in C. DP were divided During an initial study phase comprising 6 air-free dialysis treatments
in each patient, it became apparent that the LMWH (Dalteparin; DP)in quartiles. Hyperfiltration (GFR . 130 ml/min/1.73m2) was found in
the highest quartile (n513). These patients were compared with the anticoagulant dose supplied as a single i.v. bolus could be gradually
reduced to a maximum of 44 percent of the dose required initiallypatients in the lowest quartile (n513, GFR was 10062 ml/min/1.73m2).
Age (26.561.8 and 27.861.9 yr) and diabetes duration (8.460.6 and (during air-containing dialysis) without causing visible clot formation
in the extracorporeal circuit (P1 from 4000 to 2500, P2 8000 to 4500,8.260.8 yr) were comparable in both groups. There were no significant
differences between non-hyperfiltrating and hyperfiltrating DP with P3 8500 to 5000 aXa IU/ml). Following this phase, each patient under-
went two dialysis treatments without-air and two times with-air usingrespect to blood pressure (MAP 80.561.8 versus 82.562.0 mmHg),
Na-Li-CT (Vmax and Km 733670 and 5564 and 82661.8 and 7064 the optimized DP-dose for air-free dialysis. The results show that
considerable enhancement of coagulation (activation peptides F1 1 2,respectively), plasma volume (29006143 versus 31146156 ml), TERalb
TAT), fibrinolysis (activation peptides D-dimer, PAP) and of visible(5.160.6 versus 4.960.4 %/hr) and HbA1c (8.460.4 versus 8.460.4 %).
clot formation within the extracorporeal circuit could be observed inThere was just a trend of an increased AER in hyperfiltrating DP
the air-containing dialysis treatments in comparison with the air-free(6.461.3 versus 9.161.3 mg/min). Conclusion: Hyperfiltration in pa-
dialysis, with similar plasma aXa levels (air-free: mean 0.18 iU/ml,tients with uncomplicated IDDM is not related to BP, Na-Li-CT,
median 0.21 iU/ml (range 0–0.34) vs with-air: mean 0.14 iU/ml, medianplasma volume, capillary or glomerular leakage of albumin or meta-
0.13 iU/ml (range 0–0.31), Table 1).bolic control. Follow-up studies will reveal if hyperfiltration is associ-
ated with the development of DNP.
Air-free dialysis Dialysis with air
15 240 increase 15 240 increaseParental syndrome-X features and predisposition to nephropathy in
min min % min min %offspring with type 1 diabetes mellitus. G. Vervoort, B. Verhage, C.
Wolkotte, L. Elving, J.F.M. Wetzels, P. Smits, A. Verbeek and J.H.M. F112 U/ml 1.76 1.78 0.1 1.78 3.83 104
Berden. Departments of Medicine and Epidemiology, University Hospi- TAT nmol/l 4.55 11.93 128 7.00 58.20 685
tal, Nijmegen, The Netherlands. Diabetic nephropathy (DNP) is a major D-dimer lg/l 325 378 11 432 640 50
contributor to the increased morbidity and mortality which develops PAP lg/l 476 572 21 480 850 71
in 20–30% of IDDM patients. Microalbuminuria is at present the Visible clots no yes
best predictor for overt DNP. However, micro-albuminuria is also
associated with other metabolic and clinical abnormalities like hyper- We conclude that air-free hemodialysis requires considerably less anti-
tension, coronary artery disease, insulin resistance, glucose intolerance coagulation compared to conventional hemodialysis without relevant
and dyslipidaemia. This spectrum of associated abnormalities has been enhancement of fibrin formation. These observations support further
described as “syndrome-X”. Familial clustering of DNP has been re- development of air-free dialysis systems which may be of benefit for
ported. We hypothesised that familial predisposition for the develop- future treatment of patients with an enhanced bleeding risk.
ment of DNP in IDDM could be due to genetic factors, expressed as
features of syndrome-X. In this cross-sectional study we compared
syndrome-X related parameters in 100 parents of IDDM patients with Non-glucose dialysis solutions in patients with ultrafiltration failure
DNP (n529) and without DNP (n528). Parents were matched on age (UFF). M.M. Ho-dac-Pannekeet, D.G. Struijk, E.W. Boeschoten, M.A.
of offspring. All parents were investigated in a fasting state. Anthropo- Friedlander, R.T. Krediet. Dept. of Nephrology, Academic Medical
metric parameters as BMI, waist/hip ratio and fat-percentage were Center, Amsterdam, the Netherlands, and Case Western University Hos-
measured. The following parameters were evaluated: lipids, NEFA’s, pital, Cleveland, Ohio, USA. Ultrafiltration failure occurs mainly in
HbA1c, uric acid and albuminuria. Blood pressure was recorded in the long-term peritoneal dialysis patients. The decrease in peritoneal func-
tion is probably related to the continuous exposure of the peritoneumsupine position using an automatic device and ankle/brachial index
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to glucose based dialysis solutions. Glucose induces non-enzymatic immuno assay (EIA) yielded 79 reactive sera. The presence of anti-
HCV was confirmed in 70 patients with a Line Immuno Assay. Allglycosylation (NEG) of proteins within the peritoneal cavity. The ad-
vanced glycosylation end-product (AGE) pentosidine is for 95% bound seropositive samples were tested by reversed transcriptase PCR (RT-
PCR) and 57 samples were found to contain HCV RNA. Of the 9to serum proteins. Its presence in dialysate is therefore mainly caused
by a wash-out phenomenon of locally formed AGEs, and not by trans- EIA-positive and Line Immuno Assay negative or indeterminate sera
4 were HCV RNA positive. All seronegative samples were screenedport from the circulation. Effluent pentosidine can therefore be used
to estimate NEG in peritoneal tissues. In the present study the effect for the presence of HCV RNA after pooling of 5 sera. Of 2576 antibody-
negative samples, 6 contained HCV RNA. The prevalence of HCVof withdrawal of glucose based dialysate on peritoneal permeability
and on effluent pentosidine was analyzed. Six patients with UF failure infections among Dutch dialysis patients as determined by serology
or presence of HCV RNA was 3% (80/2653); 3.5% (73/2108) in patients(mean UF 128ml/4hr on 3.86% glucose, range 29 to 390) were treated
with a combination of glycerol and glucosepolymer based dialyate for treated with hemodialysis and 1.3% (7/545) in patients on CAPD
(Odds-ratio 2.76; 95% confidence interval 1.26–6.02). Of these 80 HCV6 weeks. Standard peritoneal permeability analyses were performed
using glucose 3.86% dialysate at the start and after 6 weeks of treat- infected patients 67 (84%) were HCV RNA positive. Serological screen-
ing alone would have diagnosed only 70 infected patients, so 10 (12.5%)ment. Pentosidine was determined in 4-hour effluent on similar time
points. Median duration of PD treatment was 44 months (range 12–96). HCV positive patients would have been missed. Therefore, antibody
screening combined with the detection of HCV RNA should be consid-After 6 weeks net UF increased to 367ml (P,0.03). Transcapillary
ultrafiltration increased from 2.23 to 2.92 ml/min/1.73m2 (P50.04). The ered as the gold standard for diagnosing HCV infection in dialysis
patients. The prevalence of HCV infected patients in Dutch dialysismaximal change in D/P Na1 (a parameter of channel-mediated water
transport) was 20.04 vs 20.01 at start (P50.05). Glucose absorption centers ranged from 0% to 8%. The size of a dialysis center was not
related with the prevalence of HCV infection, suggesting the existencedecreased from 8365 to 7463% (P50.04), the mass transfer area
coefficient of creatinine (MTACcr) from 15.361.2 to 13.961.3 ml/min/ of local risk factors for acquiring HCV infection. Genotyping analysis
by reverse hybridization Line Probe Assay revealed the presence of1.73m2 (P50.09). Effluent pentosidine decreased from 25.2 to 20.2
pmol/mg protein (P50.06). These data indicate an improvement of genotypes 1a (23%), 1b (46%), 2 (3%), 2a (13%), 2b (1%), 3a (7%)
and 4a (4%). In 4 (6%) samples multiple genotypes were detected.ultrafiltration after treatment with non-glucose dialysate in patients
with UFF. This is caused by a decrease in the vascular peritoneal surface The genotype distribution of HCV isolates among Dutch dialysis pa-
tients was similar to the distribution among non-dialysis patients fromarea (decreases of MTACcr and glucose absorption), and improved
channel-mediated water transport (better sieving of sodium). It is ac- the Belgium, Netherlands and Luxembourg, except for subtype 1a,
which was significantly more prevalent among dialysis patientscompanied by a decrease in effluent pentosidine, indicating a decline
in the glycosylation status of the peritoneal membrane. It can be con- (P50.005) and for patients with multiple genotypes (P50.03). In only
1 center a high prevalence of an uncommon genotype was suggestivecluded that non-glucose dialysis solutions lead to improvement of peri-
toneal function and membrane glycosylation. from a common source.
Intermittent induction of the acute phase response by clinical hemodial-Colloidal Bismuth subcitrate induced nephrotoxicity: reversibility and
morphology. B.T. Leussink, A. Slikkerveer, M.R.W. Engelbrecht, E. ysis. W.E.M. Schouten, M.P.C. Grooteman, C.E. Hack, M. Schoorl,
A.J. van Houte, M.J. Nube´. Departments of Nephrology and Immunohe-de Heer, G.B. van der Voet, F.A. de Wolff, J.A. Bruijn. Lab. for Hum.
Toxicol. and Dept. of Path., Leiden University Medical Centre. Colloidal matology, Medical Centre Alkmaar; Central Laboratory of the Blood
Transfusion Service, The Netherlands. Introduction: In long term hemo-Bismuth subcitrate (CBS) is used in combination with antibiotics to
eradicate Helicobacter pylori, a now well known cause of peptic ulcer. dialysis (HD) morbidity may result from the repetitive induction of
the acute phase response, caused by the bioincompatible membraneOverdosing of CBS has been reported to result in serious but reversible
nephrotoxicity in humans. In this study, the nephrotoxicity of a single and or contaminated dialysate. The aim of the present study was to
investigate HD-induced cytokine production and subsequent produc-CBS overdose was studied in detail by using a rat model. A single oral dose
of CBS containing 0, 750, 1500 or 3000 mmol Bi/kg was administered by tion of acute phase proteins, such as C-reactive protein (CRP) and
secretory phospholipase A2 (sPLA2), in the inter-dialytic interval.gavage to 4 groups of twenty female Wistar rats. Kidney function
parameters and Bi content were monitored in blood and urine. Animals Methods: In 11 patients, IL-6, CRP and sPLA2 levels were assessed
in bloodsamples drawn before (t0), at the end (t180) and 24 hourswere sacrificed 48, 96, 168, 240 or 336 hours after administration. At
a dose of 3000 mmol Bi/kg (comparable to 400 tablets of DeNolt for after the start of HD (t1440). Cuprammonium (CU), CU plus a dialy-
sate filter (CU1filter) and Polysulfon (PS) membranes were used in aa 70 kg human), two out of twenty animals died within three days
under the clinical picture of renal failure. In the rest of the animals randomized cross over design. Results: During HD using CU/CU1filter,
IL-6 levels were significantly increased at t180, compared to t0 (CU:the kidney function deteriorated as detected by elevated levels of
proteinuria, glucosuria, urinary excretion of the proximal tubular en- 3.6 pg/ml at t0 vs 10.9 pg/ml at t180, p,0.02; CU1filter: p,0.02). At
t1440, IL-6 levels were returned to baseline. In contrast, this fluctuationzyme N-acetyl-b-D-glucosaminidase (NAG), and blood urea and crea-
tinin. Within ten days these levels returned to those of the control was not noticed during HD with PS. Comparing CU/CU1filter with
PS membranes, the increment of IL-6 at t180 was significantly differentgroup. At a dose of 1500 mmol Bi/kg changes were less extensive and
lasted less than 96 hours. At a dose of 750 mmol Bi/kg, no changes in (p#0.02). Following HD with CU, a significant increase of both CRP
and sPLA2 concentrations was observed at t1440, compared to postdial-kidney function parameters were noted. Microscopic examination of
PAS-stained paraffin embedded kidney sections revealed dose-depen- ysis values (CRP: 6.3 mg/l at t180 vs 8.8 mg/l at t1440, p50.02; sPLA2:
8.5 ng/ml at t180 vs 12.5 ng/ml at t1440, p50.01). IL-6 levels at t180dent changes in the tubular epithelium starting with vacuolisation of
the cytoplasm (1500 mmol Bi/kg) and ending with complete destruction were significantly correlated with CRP (r50.78, p,0.001) and sPLA2
(r50.62, p50.01) values at t1440. During HD with PS membranes,of the tubuli (3000 mmol Bi/kg). It is concluded that in Wistar rats an
acute oral overdose of CBS primarily damages the tubular epithelial neither CRP nor sPLA2 values changed significantly. Conclusions: 1)
In contrast to PS, both CU as well as CU1filter caused elevated IL-6cells of the kidney in a dose-dependent way. The injury was shown to
be reversible within ten days. levels at the end of HD, which correlated with increased CRP and
sPLA2 levels 24 hours after HD. 2) According to these results, not the
contamination of dialysate, but rather the type of membrane seems
Hepatitis C in dialysis patients in the Netherlands. P.M. Schneeberger, to be responsible for the induction of the acute phase response during
I. Keur, W. van der Vliet, K. van Hoek, H. Boswijk, A.M. van Loon, clinical HD. 3) CRP and sPLA2 may be useful parameters of bioincom-
W.C. van Dijk, R.H. Kauffmann, W. Quint, L.-J. van Doorn. A national patibility. Key-word: Hemodialysis
Survey of Hepatitis C virus (HCV) infections among dialysis patients
in the Netherlands was performed. The study involved 2653 patients,
2108 hemodialysis and 545 CAPD patients, from 39 of the 49 dialysis Strontium loading to chronic renal failure rats induces osteomalacia.
Iris Schrooten, Patrick C. D’Haese, Walter Cabrera, Ludwig V. Lam-centers in the Netherlands. Patient sera were analyzed by both serologi-
cal and molecular methods. Screening by a third generation enzyme berts, William G. Goodman*, Marc E. De Broe. Dept. Nephrol./Hypert.
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University of Antwerp, Belgium; *Radiol. Sci UCLA, LA. The develop- Influence of amphotericin B and HgCl2 on peritoneal transport in
ment of aluminum-related bone disease (ARBD) either expressed as rabbits. M.M. Zweers, C.E. Douma, A.B. van der Wardt, R.T. Krediet,
ostemalacia or adynamic bone disease has been well documented in D.G. Struijk. Academic Medical Center, Amsterdam, The Netherlands.
dialysis patients. No evidence has been presented so far however, to Intra peritoneal (ip) administration of amphotericin B (amphoB), 5
which extent aluminum (Al) acts alone or in combination with other mg/kg, has been reported to increase ultrafiltration without an effect
trace elements. In this context our recent findings of increased bone on solute transport in acute experiments in rabbits. This suggests an
strontium (Sr) levels noted in dialysis patients with osteomalacia as effect on aquaporin mediated water transport. The mercury (Hg) sensi-
compared to those presenting the other types of renal osteodystrophy tive water-channel aquaporin-1 has been demonstrated in endothelial
(JASN 6, 935, 1995) is of particular interest. In an experimental study cells of the peritoneal microvasculature. The aim of the study was to
using the remnant kidney model, 3 groups of 8 rats each were studied: investigate the influence of ip administration of amphoB in a dose
a control group (C-g) and a group of animals loaded with either Sr similar to that employed in PD patients with fungal peritonitis, and
(S-g) or Al (A-g). Sr was administered orally by adding 1.0g/100 mL of HgCl2 in a chronic rabbit peritoneal dialysis model. 14 / NZW
of SrCL2·6H2O (0.3% Sr) to the drinking water during a 12-week rabbits (2664 g, range 2364–3005 g) underwent a standard peritoneal
period. The latter solution did not contain any Al. Al was administered permeability analysis for rabbits (SPAR) during a 1-hour dwell with
orally 6 days a week by adding 10g/kg Al(OH)3 to the rat chow, as 3.86% glucose dialysate. Dextran 70 was added to calculate fluid kinet-
well as of 10mg/L of Al to the drinking water. A solution of 17.9 ics. In 9 rabbits 0.06 mg/kg body weight amphoB was added to the
mg AlCl3·6H2O and 15.6 mg citrate dissolved in saline was injected dialysate during 3 consecutive days. In 5 of these rabbits amphoB was
intraperitoneally on day 7. Control and Sr loaded animals received an also administered during 5 days. 12 rabbits underwent a SPAR with
intraperitoneal injection of a solution of 15.6 mg citrate in saline. Water 0.1 mM HgCl2 containing 3.86% glucose dialysate. The animals wereand food consumption was checked daily in all groups. Rats were fed anesthetized during the last experiment. Addition of amphoB duringby paired feeding and were weighed weekly. As compared to the C-g either 3 or 5 day treatment caused no change in the Ddialysate/plasmagroup administration of Sr or Al resulted in markedly increased bone
ratio of sodium (DD/P Na), calculated as the initial D/P Na minus thelevels of the respective elements. Histological examination revealed
minimal D/P Na during the dwell. Also no effect was found on thethat there were no differences in bone surface area and erodic perime-
transcapillary ultrafiltration, lymphatic absorption, transport rate ofter between the 3 groups. Compared to the control group however,
small solutes or albumin clearance. This suggests that amphoB, in thisbone formation rate (S-g: 1766246 and A-g: 6736578 vs. C-g:18696788
dosage does not influence aquaporin-1 mediated water transport duringmm2/mm2/day, p,0.001) and mineral apposition rate (S-g: 0.4460.62
stable peritoneal dialysis in this rabbit model. HgCl2 caused a significantand A-g: 0.9560.75 vs. C-g: 1.4760.16 mm/day, p,0.001 and 0.05 re-
reduction (p,0.009) of DD/P Na: 0.031 (range) (0.013–0.08) in controlsspectively) were significantly lower and mineralisation lag time (S-g:
to 0.008 (0.000–0.090). The MTAC of urea increased (p,0.02) from337862285 and A-g: 214662670 vs. C-g: 0.9460.56 days) significantly
18.4 mL/min/1.73m2 (13.8–35.8) to 21.5 mL/min/1.73m2 (13.4–35.9).higher in both the A-g and S-g. Bone formation rate and mineral
Also the albumin clearance was significantly greater (p,0.06): 361apposition also was significantly (p,0.05) lower in the S-g as compared
mL/min/1.73m2 (120–820) to 1046 mL/min/1.73m2 (219–2520), althoughto A-g. Interestingly, whereas in the S-g the reduced bone formation
plasma values were not different. Fluid kinetics were similar to thewent along with a significant increase in osteoid area (S-g: 6.061.89 vs.
control values. In conclusion, amphoB ip in the dose that can beC-g: 0.8560.64, p50.001), this was not the case in the A-g (0.8861.25,
administered to humans did not affect peritoneal transport. HgCl2p,0.005 vs. Sr). In contrast to the A-g was there an increased calciuria
inhibited aquaporin mediated water transport. This was not reflectedin the S-g. Our findings indicate that Sr accumulation in chronic renal
in lower ultrafiltration rates, possibly because of counteraction onfailure rats results in the development of osteomalacia whereas rats
loaded with Al rather seem to develop adynamic bone lesions. peritoneal transport of solutes by its toxic effects.
